Veterinary Infectious Disease Diagnostics Market by Product (Consumables, Instruments), Technology (Molecular Diagnostic, PCR, ELISA, Immunodiagnostics, Rapid Tests), Animal Type (Companion Animal, Livestock), End User & Region - Global Forecast to 2030

icon1
USD 4.22 BN
MARKET SIZE, 2030
icon2
CAGR 8.0%
(2025-2030)
icon3
545
REPORT PAGES
icon4
699
MARKET TABLES

OVERVIEW

Veterinary Infectious Disease Diagnostics Market Overview

Source: Secondary Research, Interviews with Experts, MarketsandMarkets Analysis

The veterinary infectious disease diagnostics market is projected to reach USD 4.22 billion by 2030 from USD 2.87 billion in 2025, at a CAGR of 8.0% from 2025 to 2030. This market encompasses diagnostic tools, kits, and technologies designed for the detection, monitoring, and prevention of infectious diseases in companion animals and livestock. Growth is strongly driven by the increasing prevalence of zoonotic and infectious diseases, alongside the rise in pet ownership and higher spending on veterinary care. Advancements in molecular diagnostics, immunodiagnostics, and rapid point-of-care testing kits are improving the accuracy, speed, and accessibility of disease detection. The expansion of veterinary hospitals & clinics and veterinary reference laboratories, as well as government-led initiatives and regulatory frameworks promoting animal health surveillance and biosecurity, further support market uptake. Moreover, the rising demand for early diagnosis, preventive health solutions, and on-site testing to limit disease transmission is expected to accelerate adoption in both developed and emerging markets over the coming years.

KEY TAKEAWAYS

  • BY PRODUCT
    The veterinary infectious disease diagnostics market is divided into consumables and instruments. Consumables, including reagents and test kits, are extensively utilized for routine diagnostics and point-of-care applications, whereas instruments such as analyzers play a critical role in delivering advanced, precise, and reliable disease detection.
  • BY TECHNOLOGY
    The veterinary infectious disease diagnostics market spans immunodiagnostics, molecular diagnostics, and other technologies. Immunodiagnostics are widely adopted for routine disease screening and rapid detection of infectious agents, while molecular diagnostics provide highly sensitive and specific pathogen identification, enabling early and accurate diagnosis, with other technologies contributing to specialized testing needs.
  • BY ANIMAL TYPE
    Key segments include companion animals and livestock, with demand shaped by rising pet ownership, growing expenditure on companion animal healthcare, and the need for effective disease management in livestock to ensure productivity, food safety, and cost efficiency. The segments are further segmented by technology as well.
  • BY END USER
    Veterinary reference laboratories dominate the market due to their advanced infrastructure, high testing capacity, and specialized expertise. They are followed by veterinary hospitals & clinics, point-of-care/in-house testing, and research institutes & universities, which are steadily expanding adoption for preventive care and innovation.
  • BY REGION
    The Asia Pacific is expected to grow fastest, at a CAGR of 9.4% driven by rising pet ownership, expanding livestock populations, strengthening veterinary infrastructure, and increasing investments in animal health across key countries such as China, India, and Japan.
  • COMPETITIVE LANDSCAPE
    Leading players in the market pursue both organic and inorganic strategies, including new product launches, collaborations, and acquisitions. Companies such as IDEXX Laboratories, Inc., Zoetis Services LLC, and Antech Diagnostics, Inc. have broadened their portfolios and formed strategic partnerships to enhance their diagnostic capabilities and address the growing demand for advanced veterinary infectious disease testing solutions.

The veterinary infectious disease diagnostics market is set to experience robust growth over the coming decade, fueled by rising pet ownership, growing demand for advanced veterinary care, and ongoing innovations in diagnostic technologies. Key tools such as ELISA and PCR tests are witnessing greater adoption to support accurate pathogen detection, early intervention, and improved treatment outcomes. The increasing burden of infectious diseases in both companion and livestock animals, along with the heightened emphasis on preventive healthcare and biosecurity, is further accelerating market expansion. In addition, the growth of veterinary clinics and reference laboratories, rising investments in animal health, and the integration of rapid and point-of-care testing solutions are enhancing diagnostic accessibility and efficiency. With a broadening global animal population and a stronger focus on timely and precise infectious disease management, this market is poised to play a critical role in advancing animal health worldwide.

TRENDS & DISRUPTIONS IMPACTING CUSTOMERS' CUSTOMERS

The veterinary infectious disease diagnostics market is shaped by evolving animal healthcare priorities and industry-wide disruptions. Core customers include veterinary clinics & hospitals, reference laboratories, and research institutes, which rely heavily on infectious disease testing to protect both companion and livestock animal health. Key trends such as the rising demand for early and precise pathogen detection, growing adoption of point-of-care and rapid diagnostic tools, heightened emphasis on preventive care and biosecurity, and tightening regulatory requirements are transforming operational models and revenue streams for service providers. These shifts are driving greater investment in diagnostic consumables and instruments, directly influencing the growth prospects and competitiveness of infectious disease diagnostic manufacturers.

Veterinary Infectious Disease Diagnostics Market Disruptions

Source: Secondary Research, Interviews with Experts, MarketsandMarkets Analysis

MARKET DYNAMICS

Drivers
Impact
Level
  • Growing concerns about infectious zoonotic diseases
  • Growth in companion animal population
RESTRAINTS
Impact
Level
  • High cost of veterinary diagnostic tests
  • Rising pet care costs
OPPORTUNITIES
Impact
Level
  • Integration of AI and ML
  • Growth potential of emerging economies
CHALLENGES
Impact
Level
  • Shortage of veterinary practitioners in emerging economies
  • Low animal healthcare awareness in emerging countries

Source: Secondary Research, Interviews with Experts, MarketsandMarkets Analysis

Driver: Growing concerns about infectious zoonotic diseases

Rising concerns about infectious zoonotic diseases, which pose risks to both animal and human health, are a significant driver of the veterinary infectious disease diagnostics market. Outbreaks of diseases such as avian influenza, rabies, leptospirosis, and brucellosis have underscored the urgent need for early and accurate diagnostic solutions to prevent transmission and ensure effective containment. Veterinary diagnostics play a pivotal role in strengthening surveillance systems, supporting timely interventions, and reducing the economic and social impact of zoonotic outbreaks. This heightened awareness is driving wider adoption of immunodiagnostics, molecular tools, and rapid point-of-care tests across both companion animal and livestock sectors.

Restraint: High cost of veterinary diagnostic tests

The high cost of veterinary diagnostic tests remains a key restraint for the veterinary infectious disease diagnostics market. Advanced tools such as molecular assays and specialized immunodiagnostics offer superior accuracy but often come with substantial expenses related to equipment, reagents, and maintenance. These costs can be prohibitive for smaller veterinary clinics, livestock farmers, and pet owners, particularly in developing regions with limited healthcare budgets. As a result, adoption rates may be slowed, creating disparities in access to timely and accurate disease detection. Overcoming this barrier will require innovations in cost-effective testing solutions, wider availability of point-of-care kits, and supportive government or industry initiatives to improve affordability.

Opportunity: Integration of AI and ML

The integration of AI and machine learning is a major growth opportunity for the veterinary infectious disease diagnostics market. These technologies enhance diagnostic accuracy by enabling faster analysis of complex data, predicting disease outbreaks, and supporting real-time decision-making. AI- and ML-powered tools help veterinarians identify infections earlier, optimize treatment plans, and improve overall animal health management, driving greater adoption of advanced diagnostic solutions across both companion animals and livestock.

Challenge: Shortage of veterinary practitioners in emerging economies

The shortage of veterinary practitioners in emerging economies poses a significant challenge for the veterinary infectious disease diagnostics market. Limited availability of trained professionals can restrict the proper use and interpretation of advanced diagnostic tools, slowing the adoption of sophisticated tests such as molecular assays and immunodiagnostics. This gap often leads to delays in disease detection and management, particularly in rural or resource-limited regions, hindering market growth and the effective control of infectious diseases in both companion animals and livestock.

Veterinary Infectious Disease Diagnostics Market: COMMERCIAL USE CASES ACROSS INDUSTRIES

COMPANY USE CASE DESCRIPTION BENEFITS
Offers a range of diagnostic solutions, including the SNAP Tests for detecting infectious diseases in companion animals. These tests provide rapid and reliable results, aiding veterinarians in making timely treatment decisions Rapid diagnostics | Reliable results | Enhanced treatment decisions for companion animals
Provides diagnostic tools, such as the Witness rapid tests, for detecting infectious diseases in animals. These tools are designed to support veterinarians in diagnosing and managing infectious diseases effectively Effective disease management and support for veterinarians in diagnosing infections
Offers the VetMAX PCR assays for detecting infectious diseases in animals. These molecular diagnostic tools enable precise identification of pathogens Precise pathogen identification and support for veterinary diagnostics
Provides the Rapid test kits for detecting infectious diseases in animals. These kits are designed for use in veterinary practices to support disease diagnosis Convenient in-clinic diagnostics and support for disease detection
Offers the VITEK 2 platform for antimicrobial susceptibility testing in veterinary diagnostics. This system aids in identifying pathogens and determining appropriate treatments Enhanced pathogen identification and antimicrobial resistance monitoring

Logos and trademarks shown above are the property of their respective owners. Their use here is for informational and illustrative purposes only.

MARKET ECOSYSTEM

The veterinary infectious disease diagnostics market ecosystem comprises diagnostic solution manufacturers, distributors, veterinary clinics, hospitals, reference laboratories, and research institutions, all working together to support comprehensive animal healthcare. Manufacturers drive innovation by developing advanced immunodiagnostics, molecular tests, and specialized reagents, while distributors ensure efficient delivery across regional and global markets. Veterinary professionals serve as the primary end users, supported by collaborations with research organizations and regulatory authorities that maintain quality, safety, and compliance standards. Strategic partnerships and investments are also enhancing access to diagnostic solutions, promoting wider adoption, and meeting the growing need for accurate, timely infectious disease detection in both companion animals and livestock worldwide.

Veterinary Infectious Disease Diagnostics Market Ecosystem

Logos and trademarks shown above are the property of their respective owners. Their use here is for informational and illustrative purposes only.

MARKET SEGMENTS

Veterinary Infectious Disease Diagnostics Market Segments

Source: Secondary Research, Interviews with Experts, MarketsandMarkets Analysis

Veterinary Infectious Disease Diagnostics Market, By Product

In the veterinary infectious disease diagnostics market, consumables account for the largest share because they are required in every diagnostic test, ensuring repeated and continuous demand. Reagents, kits, and assay components are essential for conducting PCR, ELISA, rapid tests, and other diagnostic procedures, making them indispensable in both routine and advanced testing. Unlike instruments, which are one-time investments, consumables generate recurring revenue, driving consistent market growth. Their critical role in delivering accurate and timely results further strengthens their dominance in this segment.

Veterinary Infectious Disease Diagnostics Market, By Technology

The immunodiagnostics segment dominated the overall veterinary infectious disease diagnostics market in 2024. This large share is mainly due to its wide applicability, ease of use, and rapid results. Immunodiagnostic tests, including ELISA kits and lateral flow assays, are extensively used for routine screening, early detection of infectious agents, and monitoring of disease progression in both companion animals and livestock. Their cost-effectiveness, reliability, and ability to deliver timely results at point-of-care settings make them highly preferred by veterinary clinics, reference laboratories, and field practitioners, driving strong demand across the market.

Veterinary Infectious Disease Diagnostics Market, By Animal Type

The companion animals segment of the veterinary infectious disease diagnostics market accounted for the largest share in 2024 because of the rising rates of pet ownership, increasing expenditures on veterinary care, and growing awareness of preventive healthcare. Pet owners are increasingly investing in advanced diagnostic tests to ensure early detection and management of infectious diseases, improve treatment outcomes, and maintain overall animal health. The strong focus on wellness, routine screenings, and point-of-care testing in companion animals drives consistent demand, making this segment the dominant contributor to market growth.

Veterinary Infectious Disease Diagnostics Market, By End User

In 2024, veterinary reference laboratories held the largest share of the veterinary infectious disease diagnostics market due to their advanced infrastructure, high testing capacity, and specialized expertise. These laboratories handle large volumes of diagnostic tests, including complex molecular and immunodiagnostic assays, ensuring accurate and timely detection of infectious diseases. Their ability to provide comprehensive testing services, support research, and maintain high quality standards makes them the preferred choice for both companion animal and livestock diagnostics, driving strong adoption and reinforcing their dominance in the market.

REGION

Asia Pacific to be fastest-growing region in global veterinary infectious disease diagnostics market during forecast period

The Asia Pacific veterinary infectious disease diagnostics market is expected to register the highest CAGR in 2024, driven by rising pet ownership, expanding livestock populations, and increasing investments in animal healthcare infrastructure. Countries like China, India, and Japan are witnessing greater adoption of advanced diagnostic technologies, including immunodiagnostics and molecular tests, to address the growing prevalence of infectious diseases. Additionally, government initiatives supporting preventive care, biosecurity, and veterinary modernization are accelerating market growth, making the region a key contributor to global expansion.

Veterinary Infectious Disease Diagnostics Market Region

Veterinary Infectious Disease Diagnostics Market: COMPANY EVALUATION MATRIX

In the veterinary infectious disease diagnostics market matrix, IDEXX Laboratories, Inc. (Star) leads with a strong global footprint and a comprehensive portfolio of immunodiagnostics, molecular tests, and reagents, driving widespread adoption across veterinary clinics, hospitals, and reference laboratories. Antech Diagnostics, Inc. (Emerging Leader) is gaining momentum with innovative diagnostic solutions focused on infectious disease testing for companion animals, positioning itself for rapid growth. While IDEXX maintains dominance through scale and established market leadership, Antech shows strong potential to move further toward the leaders’ quadrant.

Veterinary Infectious Disease Diagnostics Market Evaluation Matrics

Source: Secondary Research, Interviews with Experts, MarketsandMarkets Analysis

KEY MARKET PLAYERS

MARKET SCOPE

REPORT METRIC DETAILS
Market Size in 2024 (Value) USD 2.66 BN
Market Forecast in 2030 (Value) USD 4.22 BN
CAGR CAGR of 8.0% from 2025–2030
Years Considered 2023–2030
Base Year 2024
Forecast Period 2025–2030
Units Considered Value (USD BN), Volume (Thousand Units)
Report Coverage Revenue Forecast, Company Ranking, Competitive Landscape, Growth Factors, and Trends
Segments Covered
  • By Product: Consumables and Instruments
  • By Technology:
    • Immunodiagnostics
    • Molecular Diagnostics
    • and Other Technologies
  • By Animal Type: Companion Animals and Livestock
  • By End User:
    • Veterinary Reference Laboratories
    • Veterinary Hospitals & Clinics
    • POC/In-house Testing
    • and Veterinary Research Institutes & Universities
Regional Scope North America, Europe, Asia Pacific, Latin America, and the Middle East & Africa

WHAT IS IN IT FOR YOU: Veterinary Infectious Disease Diagnostics Market REPORT CONTENT GUIDE

Veterinary Infectious Disease Diagnostics Market Content Guide

DELIVERED CUSTOMIZATIONS

We have successfully delivered the following deep-dive customizations:

CLIENT REQUEST CUSTOMIZATION DELIVERED VALUE ADDS
Product Analysis Comparison of leading veterinary infectious disease diagnostics technologies: immunodiagnostics, molecular diagnostics, and other specialized tests. Immunodiagnostics is witnessing rising adoption for routine and preventive screening, while molecular diagnostics is gaining traction for its accuracy in pathogen detection. Enables identification of technology adoption shifts across veterinary clinics, hospitals, reference laboratories, and research institutes
Highlights efficiency, accuracy, and compliance trends influencing purchasing decisions in animal healthcare
Company Information Key players: IDEXX Laboratories, Inc., Zoetis Services LLC, Antech Diagnostics, Inc., Virbac Provides insights into competitive strategies, innovation focus (e.g., AI-integrated tools, connected devices), and partnerships or M&A activities shaping the veterinary infectious disease diagnostics landscape
Geographic Analysis Detailed analysis on the Rest of APAC was provided to one of the top players. Client focused on ASEAN market country-level analysis for the device market. Country-level demand mapping for new product launches and localization strategy planning

RECENT DEVELOPMENTS

  • June 2025 : bioMérieux launched VETFIRE, a ready-to-use PCR kit tailored for equine infectious respiratory diseases, capable of simultaneously detecting seven different respiratory pathogens in horses.
  • May 2025 : Zoetis Services LLC opened a new Diagnostics Reference Laboratory at the UPS Healthcare Labport facility, offering expanded capacity and enhanced logistics to meet the rising demand for veterinary diagnostic services and enable more efficient testing and delivery across the region.
  • January 2025 : BioNote introduced a one-step rapid test for Canine Heartworm (CHW), designed to save time and resources during in-clinic screening for this potentially life-threatening infection.
  • August 2024 : BioChek collaborated with Bio-X Diagnostics to enhance the capabilities of both organizations in animal health diagnostics. Additionally, BioChek acquired a minority stake in Bio-X, supporting the global distribution of Bio-X’s products.

 

Table of Contents

Exclusive indicates content/data unique to MarketsandMarkets and not available with any competitors.

TITLE
PAGE NO
1
INTRODUCTION
 
 
 
47
2
RESEARCH METHODOLOGY
 
 
 
52
3
EXECUTIVE SUMMARY
 
 
 
68
4
PREMIUM INSIGHTS
 
 
 
74
5
MARKET OVERVIEW
Surging pet ownership and tech-driven diagnostics fuel booming veterinary market growth.
 
 
 
78
 
5.1
MARKET DYNAMICS
 
 
 
 
 
5.1.1
DRIVERS
 
 
 
 
 
5.1.1.1
GROWTH IN COMPANION ANIMAL POPULATION
 
 
 
 
5.1.1.2
INCREASING DEMAND FOR ANIMAL-DERIVED FOOD PRODUCTS
 
 
 
 
5.1.1.3
GROWING CONCERNS ABOUT INFECTIOUS ZOONOTIC DISEASES
 
 
 
 
5.1.1.4
RISING DEMAND FOR PET INSURANCE AND GROWING ANIMAL HEALTH EXPENDITURE
 
 
 
 
5.1.1.5
INCREASING NUMBER OF VETERINARY PRACTITIONERS AND RISING INCOME LEVELS IN DEVELOPED MARKETS
 
 
 
 
5.1.1.6
GROWING FOCUS ON DISEASE CONTROL & PREVENTION MEASURES
 
 
 
5.1.2
RESTRAINTS
 
 
 
 
 
5.1.2.1
RISING PET CARE COSTS
 
 
 
 
5.1.2.2
HIGH COST OF VETERINARY DIAGNOSTIC TESTS
 
 
 
5.1.3
OPPORTUNITIES
 
 
 
 
 
5.1.3.1
GROWTH POTENTIAL OF EMERGING ECONOMIES
 
 
 
 
5.1.3.2
INTEGRATION OF AI & ML
 
 
 
5.1.4
CHALLENGES
 
 
 
 
 
5.1.4.1
LOW ANIMAL HEALTHCARE AWARENESS IN EMERGING COUNTRIES
 
 
 
 
5.1.4.2
SHORTAGE OF VETERINARY PRACTITIONERS IN EMERGING ECONOMIES
 
 
5.2
INDUSTRY TRENDS
 
 
 
 
 
5.2.1
ADOPTION OF MULTIPLE TEST PANELS
 
 
 
 
5.2.2
OUTSOURCING OF VETERINARY DIAGNOSTIC TESTING SERVICES
 
 
 
 
5.2.3
GROWING SCALE OF VETERINARY BUSINESSES
 
 
 
5.3
TECHNOLOGY ANALYSIS
 
 
 
 
 
5.3.1
KEY TECHNOLOGIES
 
 
 
 
 
5.3.1.1
PORTABLE INSTRUMENTS FOR POC DIAGNOSTIC SERVICES
 
 
 
 
5.3.1.2
BIOSENSOR-BASED DIAGNOSTIC SYSTEMS
 
 
 
5.3.2
ADJACENT TECHNOLOGIES
 
 
 
 
 
5.3.2.1
WEARABLE BIOSENSORS & REMOTE MONITORING DEVICES
 
 
 
 
5.3.2.2
RAPID & SENSITIVE VETERINARY DIAGNOSTIC KITS
 
 
 
 
5.3.2.3
BREATH & SALIVA-BASED DIAGNOSTIC TOOLS
 
 
 
 
5.3.2.4
MICROFLUIDICS & LAB-ON-A-CHIP DEVICES
 
 
 
5.3.3
COMPLEMENTARY TECHNOLOGIES
 
 
 
 
 
5.3.3.1
AI-DRIVEN DIAGNOSTIC PLATFORMS
 
 
 
 
5.3.3.2
NEXT-GENERATION SEQUENCING (NGS)
 
 
5.4
PORTER’S FIVE FORCES ANALYSIS
 
 
 
 
 
5.4.1
THREAT OF NEW ENTRANTS
 
 
 
 
5.4.2
THREAT OF SUBSTITUTES
 
 
 
 
5.4.3
BARGAINING POWER OF SUPPLIERS
 
 
 
 
5.4.4
BARGAINING POWER OF BUYERS
 
 
 
 
5.4.5
INTENSITY OF COMPETITIVE RIVALRY
 
 
 
5.5
REGULATORY ANALYSIS
 
 
 
 
 
5.5.1
REGULATORY LANDSCAPE
 
 
 
 
5.5.2
REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
 
 
 
 
 
5.5.2.1
NORTH AMERICA
 
 
 
 
5.5.2.2
EUROPE
 
 
 
 
5.5.2.3
REST OF THE WORLD
 
 
5.6
PATENT ANALYSIS
 
 
 
 
 
 
5.6.1
PATENT PUBLICATION TRENDS FOR VETERINARY INFECTIOUS DISEASE DIAGNOSTICS
 
 
 
 
5.6.2
JURISDICTION & TOP APPLICANT ANALYSIS
 
 
 
5.7
TRADE ANALYSIS
 
 
 
 
 
 
5.7.1
TRADE DATA FOR HS CODE 9018
 
 
 
 
 
5.7.1.1
IMPORT DATA FOR HS CODE 9018
 
 
 
 
5.7.1.2
EXPORT DATA FOR HS CODE 9018
 
 
5.8
PRICING ANALYSIS
 
 
 
 
 
 
5.8.1
AVERAGE SELLING PRICE TREND OF KEY PLAYERS, BY PRODUCT, 2022–2024
 
 
 
 
5.8.2
AVERAGE SELLING PRICE, BY REGION, 2022–2024
 
 
 
 
 
5.8.2.1
AVERAGE SELLING PRICE OF ELISA AND PCR TEST KITS, BY REGION, 2024
 
 
 
 
5.8.2.2
AVERAGE SELLING PRICE TREND OF ELISA TEST KITS (PER 96-WELL KIT), BY REGION, 2022–2024
 
 
 
 
5.8.2.3
AVERAGE SELLING PRICE TREND OF LATERAL FLOW RAPID TESTS (PER UNIT), BY REGION, 2022–2024
 
 
 
 
5.8.2.4
AVERAGE SELLING PRICE TREND OF PCR TEST KITS (VETERINARY PANELS), BY REGION, 2022–2024
 
 
 
 
5.8.2.5
AVERAGE SELLING PRICE TREND OF IMMUNOASSAY ANALYZERS (BENCHTOP), BY REGION, 2022–2024
 
 
 
 
5.8.2.6
AVERAGE SELLING PRICE TREND OF HIGH-END IMMUNOASSAY ANALYZERS, BY REGION, 2022–2024
 
 
 
 
5.8.2.7
AVERAGE SELLING PRICE TREND OF NUCLEIC ACID SEQUENCERS (BENCHTOP), BY REGION, 2022–2024
 
 
5.9
REIMBURSEMENT ANALYSIS
 
 
 
 
5.10
KEY CONFERENCES & EVENTS, 2025–2026
 
 
 
 
5.11
KEY STAKEHOLDERS & BUYING CRITERIA
 
 
 
 
 
 
5.11.1
KEY STAKEHOLDERS IN BUYING PROCESS
 
 
 
 
5.11.2
BUYING CRITERIA
 
 
 
5.12
END-USER PERSPECTIVE & UNMET NEEDS
 
 
 
 
5.13
IMPACT OF AI ON VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET
 
 
 
 
 
 
5.13.1
INTRODUCTION
 
 
 
 
5.13.2
MARKET POTENTIAL IN VETERINARY INFECTIOUS DISEASE DIAGNOSTICS ECOSYSTEM
 
 
 
 
5.13.3
AI USE CASES
 
 
 
 
5.13.4
KEY COMPANIES IMPLEMENTING AI IN VETERINARY INFECTIOUS DISEASE DIAGNOSTICS
 
 
 
5.14
ECOSYSTEM ANALYSIS
 
 
 
 
 
5.15
VALUE CHAIN ANALYSIS
 
 
 
 
 
5.16
SUPPLY CHAIN ANALYSIS
 
 
 
 
 
5.17
ADJACENT MARKET ANALYSIS
 
 
 
 
5.18
INVESTMENT & FUNDING SCENARIO
 
 
 
 
 
5.19
IMPACT OF 2025 US TARIFF ON VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET
 
 
 
 
 
 
5.19.1
INTRODUCTION
 
 
 
 
5.19.2
KEY TARIFF RATES
 
 
 
 
5.19.3
PRICE IMPACT ANALYSIS
 
 
 
 
5.19.4
IMPACT ON COUNTRY/REGION
 
 
 
 
5.19.5
IMPACT ON END-USE INDUSTRIES
 
 
6
VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET, BY PRODUCT
Market Size & Growth Rate Forecast Analysis to 2030 in USD Million | 6 Data Tables
 
 
 
130
 
6.1
INTRODUCTION
 
 
 
 
6.2
CONSUMABLES
 
 
 
 
 
6.2.1
RECURRENT PURCHASE OF DIAGNOSTIC KITS AND REAGENTS TO BOOST MARKET GROWTH
 
 
 
6.3
INSTRUMENTS
 
 
 
 
 
6.3.1
INCREASING DEMAND FOR POC ANALYZERS TO SUPPORT MARKET GROWTH
 
 
7
VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET, BY TECHNOLOGY
Market Size & Growth Rate Forecast Analysis to 2030 in USD Million and Units | 36 Data Tables
 
 
 
138
 
7.1
INTRODUCTION
 
 
 
 
7.2
IMMUNODIAGNOSTICS
 
 
 
 
 
7.2.1
LATERAL FLOW ASSAYS
 
 
 
 
 
7.2.1.1
LATERAL FLOW RAPID TESTS
 
 
 
 
7.2.1.2
LATERAL FLOW STRIP READERS
 
 
 
7.2.2
ELISA TESTS
 
 
 
 
 
7.2.2.1
COST-EFFECTIVENESS AND EASE OF USE TO DRIVE MARKET
 
 
 
7.2.3
IMMUNOASSAY ANALYZERS
 
 
 
 
 
7.2.3.1
HIGH SENSITIVITY & SPECIFICITY FOR BIOMARKER DETECTION TO DRIVE MARKET
 
 
 
7.2.4
OTHER IMMUNODIAGNOSTIC TECHNOLOGIES
 
 
 
7.3
MOLECULAR DIAGNOSTICS
 
 
 
 
 
7.3.1
PCR TESTS
 
 
 
 
 
7.3.1.1
INCREASED LABORATORY USAGE IN PROTEOMICS & GENOMICS TO SUPPORT GROWTH
 
 
 
7.3.2
NUCLEIC ACID SEQUENCING
 
 
 
 
 
7.3.2.1
GROWING USE OF NUCLEIC ACID SEQUENCING TO IDENTIFY PATHOGENS TO FUEL MARKET
 
 
 
7.3.3
MICROARRAYS
 
 
 
 
 
7.3.3.1
GROWING APPLICATIONS OF BIOCHIPS IN IDENTIFYING INFECTIOUS DISEASES TO DRIVE MARKET
 
 
 
7.3.4
OTHER MOLECULAR DIAGNOSTIC TECHNOLOGIES
 
 
 
7.4
OTHER TECHNOLOGIES
 
 
 
8
VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET, BY ANIMAL TYPE
Market Size & Growth Rate Forecast Analysis to 2030 in USD Million | 73 Data Tables
 
 
 
171
 
8.1
INTRODUCTION
 
 
 
 
8.2
COMPANION ANIMALS
 
 
 
 
 
8.2.1
COMPANION ANIMALS MARKET, BY ANIMAL TYPE
 
 
 
 
 
8.2.1.1
DOGS
 
 
 
 
8.2.1.2
CATS
 
 
 
 
8.2.1.3
HORSES
 
 
 
 
8.2.1.4
OTHER COMPANION ANIMALS
 
 
 
8.2.2
COMPANION ANIMALS MARKET, BY TECHNOLOGY
 
 
 
 
 
8.2.2.1
IMMUNODIAGNOSTICS
 
 
 
 
8.2.2.2
MOLECULAR DIAGNOSTICS
 
 
 
 
8.2.2.3
OTHER TECHNOLOGIES
 
 
8.3
LIVESTOCK
 
 
 
 
 
8.3.1
LIVESTOCK MARKET, BY ANIMAL TYPE
 
 
 
 
 
8.3.1.1
CATTLE
 
 
 
 
8.3.1.2
PIGS
 
 
 
 
8.3.1.3
POULTRY
 
 
 
 
8.3.1.4
OTHER LIVESTOCK
 
 
 
8.3.2
LIVESTOCK MARKET, BY TECHNOLOGY
 
 
 
 
 
8.3.2.1
IMMUNODIAGNOSTICS
 
 
 
 
8.3.2.2
MOLECULAR DIAGNOSTICS
 
 
 
 
8.3.2.3
OTHER TECHNOLOGIES
 
9
VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET, BY END USER
Market Size & Growth Rate Forecast Analysis to 2030 in USD Million | 6 Data Tables
 
 
 
243
 
9.1
INTRODUCTION
 
 
 
 
9.2
VETERINARY REFERENCE LABORATORIES
 
 
 
 
 
9.2.1
LARGE VOLUME OF TESTING SAMPLES AND AVAILABILITY OF SKILLED WORKFORCE TO PROPEL MARKET
 
 
 
9.3
VETERINARY HOSPITALS & CLINICS
 
 
 
 
 
9.3.1
GROWING PET OWNERSHIP AND SPENDING ON PET CARE TO DRIVE MARKET
 
 
 
9.4
POINT-OF-CARE/IN-HOUSE TESTING
 
 
 
 
 
9.4.1
COST-EFFECTIVENESS AND RAPID RESULTS TO BOOST DEMAND
 
 
 
9.5
VETERINARY RESEARCH INSTITUTES & UNIVERSITIES
 
 
 
 
 
9.5.1
INCREASING COLLABORATIONS BETWEEN PRIVATE COMPANIES AND RESEARCH INSTITUTES TO SUPPORT GROWTH
 
 
10
VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET, BY REGION
Comprehensive coverage of 8 Regions with country-level deep-dive of 20 Countries | 477 Data Tables.
 
 
 
252
 
10.1
INTRODUCTION
 
 
 
 
10.2
NORTH AMERICA
 
 
 
 
 
10.2.1
MACROECONOMIC OUTLOOK FOR NORTH AMERICA
 
 
 
 
10.2.2
US
 
 
 
 
 
10.2.2.1
HIGH VETERINARY HEALTHCARE EXPENDITURE TO DRIVE MARKET
 
 
 
10.2.3
CANADA
 
 
 
 
 
10.2.3.1
GROWING PET ADOPTION TO DRIVE MARKET
 
 
10.3
EUROPE
 
 
 
 
 
10.3.1
MACROECONOMIC OUTLOOK FOR EUROPE
 
 
 
 
10.3.2
GERMANY
 
 
 
 
 
10.3.2.1
RISING AWARENESS OF ZOONOTIC DISEASES TO FUEL MARKET
 
 
 
10.3.3
UK
 
 
 
 
 
10.3.3.1
INCREASING PET OWNERSHIP TO DRIVE MARKET
 
 
 
10.3.4
FRANCE
 
 
 
 
 
10.3.4.1
WILLINGNESS OF PET OWNERS TO SPEND ON PET HEALTH TO DRIVE MARKET
 
 
 
10.3.5
ITALY
 
 
 
 
 
10.3.5.1
GROWING CONSUMPTION OF MEAT & DAIRY PRODUCTS TO DRIVE MARKET
 
 
 
10.3.6
SPAIN
 
 
 
 
 
10.3.6.1
GROWING DEMAND FOR POULTRY PRODUCTS TO FUEL MARKET
 
 
 
10.3.7
NETHERLANDS
 
 
 
 
 
10.3.7.1
DEVELOPMENTS IN VETERINARY DIAGNOSTIC PRODUCTS TO SUPPORT MARKET GROWTH
 
 
 
10.3.8
REST OF EUROPE
 
 
 
10.4
ASIA PACIFIC
 
 
 
 
 
10.4.1
MACROECONOMIC OUTLOOK FOR ASIA PACIFIC
 
 
 
 
10.4.2
CHINA
 
 
 
 
 
10.4.2.1
INCREASING INCIDENCE OF ZOONOTIC DISEASES TO PROPEL MARKET
 
 
 
10.4.3
JAPAN
 
 
 
 
 
10.4.3.1
INCREASING PET EXPENDITURE TO SUPPORT MARKET GROWTH
 
 
 
10.4.4
INDIA
 
 
 
 
 
10.4.4.1
INCREASING DEMAND FOR DAIRY PRODUCTS TO DRIVE MARKET
 
 
 
10.4.5
AUSTRALIA
 
 
 
 
 
10.4.5.1
RISE IN PET OWNERSHIP TO SUPPORT MARKET GROWTH
 
 
 
10.4.6
SOUTH KOREA
 
 
 
 
 
10.4.6.1
RISING NEED FOR SPECIALIZED VETERINARY SERVICES TO DRIVE MARKET
 
 
 
10.4.7
NEW ZEALAND
 
 
 
 
 
10.4.7.1
FOCUS ON PET INSURANCE TO AID MARKET
 
 
 
10.4.8
VIETNAM
 
 
 
 
 
10.4.8.1
GROWING FOCUS ON DISEASE SURVEILLANCE TO DRIVE MARKET
 
 
 
10.4.9
REST OF ASIA PACIFIC
 
 
 
10.5
LATIN AMERICA
 
 
 
 
 
10.5.1
MACROECONOMIC OUTLOOK FOR LATIN AMERICA
 
 
 
 
10.5.2
BRAZIL
 
 
 
 
 
10.5.2.1
GROWTH IN LIVESTOCK INDUSTRY TO BOOST DEMAND
 
 
 
10.5.3
MEXICO
 
 
 
 
 
10.5.3.1
INCREASING FOCUS ON POULTRY-ASSOCIATED PRODUCTS TO SUPPORT MARKET GROWTH
 
 
 
10.5.4
REST OF LATIN AMERICA
 
 
 
10.6
MIDDLE EAST & AFRICA
 
 
 
 
 
10.6.1
MACROECONOMIC OUTLOOK FOR MIDDLE EAST & AFRICA
 
 
 
 
10.6.2
GCC COUNTRIES
 
 
 
 
 
10.6.2.1
KINGDOM OF SAUDI ARABIA (KSA)
 
 
 
 
10.6.2.2
UNITED ARAB EMIRATES (UAE)
 
 
 
 
10.6.2.3
REST OF GCC COUNTRIES
 
 
 
10.6.3
REST OF MIDDLE EAST & AFRICA
 
 
11
COMPETITIVE LANDSCAPE
Discover which key players and emerging leaders dominate market share and innovation strategies.
 
 
 
437
 
11.1
OVERVIEW
 
 
 
 
11.2
KEY PLAYER STRATEGY/RIGHT TO WIN
 
 
 
 
11.3
REVENUE ANALYSIS, 2020–2024
 
 
 
 
 
11.4
MARKET SHARE ANALYSIS, 2024
 
 
 
 
 
 
11.4.1
MARKET SHARE ANALYSIS FOR COMPANION ANIMALS
 
 
 
 
11.4.2
MARKET SHARE ANALYSIS FOR LIVESTOCK
 
 
 
 
11.4.3
RANKING OF KEY MARKET PLAYERS
 
 
 
11.5
COMPANY EVALUATION MATRIX: KEY PLAYERS, 2024
 
 
 
 
 
 
11.5.1
STARS
 
 
 
 
11.5.2
EMERGING LEADERS
 
 
 
 
11.5.3
PERVASIVE PLAYERS
 
 
 
 
11.5.4
PARTICIPANTS
 
 
 
 
11.5.5
COMPANY FOOTPRINT: KEY PLAYERS, 2024
 
 
 
 
 
11.5.5.1
COMPANY FOOTPRINT
 
 
 
 
11.5.5.2
REGION FOOTPRINT
 
 
 
 
11.5.5.3
PRODUCT FOOTPRINT
 
 
 
 
11.5.5.4
TECHNOLOGY FOOTPRINT
 
 
 
 
11.5.5.5
ANIMAL TYPE FOOTPRINT
 
 
11.6
COMPANY EVALUATION MATRIX: STARTUPS/SMES, 2024
 
 
 
 
 
 
11.6.1
PROGRESSIVE COMPANIES
 
 
 
 
11.6.2
RESPONSIVE COMPANIES
 
 
 
 
11.6.3
DYNAMIC COMPANIES
 
 
 
 
11.6.4
STARTING BLOCKS
 
 
 
 
11.6.5
COMPETITIVE BENCHMARKING: STARTUPS/SMES, 2024
 
 
 
 
 
11.6.5.1
DETAILED LIST OF KEY STARTUPS/SMES
 
 
 
 
11.6.5.2
COMPETITIVE BENCHMARKING OF KEY STARTUPS
 
 
11.7
BRAND/PRODUCT COMPARISON
 
 
 
 
 
11.8
R&D EXPENDITURE OF KEY PLAYERS
 
 
 
 
11.9
COMPANY VALUATION & FINANCIAL METRICS
 
 
 
 
 
11.9.1
FINANCIAL METRICS
 
 
 
 
11.9.2
COMPANY VALUATION
 
 
 
11.10
COMPETITIVE SCENARIO
 
 
 
 
 
11.10.1
PRODUCT LAUNCHES & ENHANCEMENTS
 
 
 
 
11.10.2
DEALS
 
 
 
 
11.10.3
EXPANSIONS
 
 
 
 
11.10.4
OTHER DEVELOPMENTS
 
 
12
COMPANY PROFILES
In-depth Company Profiles of Leading Market Players with detailed Business Overview, Product and Service Portfolio, Recent Developments, and Unique Analyst Perspective (MnM View)
 
 
 
459
 
12.1
KEY PLAYERS
 
 
 
 
 
12.1.1
IDEXX LABORATORIES, INC.
 
 
 
 
 
12.1.1.1
BUSINESS OVERVIEW
 
 
 
 
12.1.1.2
PRODUCTS & SERVICES OFFERED
 
 
 
 
12.1.1.3
RECENT DEVELOPMENTS
 
 
 
 
12.1.1.4
MNM VIEW
 
 
 
12.1.2
ZOETIS SERVICES LLC
 
 
 
 
12.1.3
THERMO FISHER SCIENTIFIC INC.
 
 
 
 
12.1.4
VIRBAC
 
 
 
 
12.1.5
BIOMÉRIEUX
 
 
 
 
12.1.6
ANTECH DIAGNOSTICS, INC.
 
 
 
 
12.1.7
INNOVATIVE DIAGNOSTICS
 
 
 
 
12.1.8
NEOGEN CORPORATION
 
 
 
 
12.1.9
INDICAL BIOSCIENCE GMBH
 
 
 
 
12.1.10
AGROLABO S.P.A.
 
 
 
 
12.1.11
BIONOTE
 
 
 
 
12.1.12
BIOGAL
 
 
 
 
12.1.13
BIOCHEK
 
 
 
 
12.1.14
MEGACOR DIAGNOSTIK GMBH
 
 
 
 
12.1.15
BIO-RAD LABORATORIES, INC.
 
 
 
12.2
OTHER PLAYERS
 
 
 
 
 
12.2.1
FASSISI, GMBH
 
 
 
 
12.2.2
BIOTANGENTS LIMITED
 
 
 
 
12.2.3
SKYER, INC.
 
 
 
 
12.2.4
BIOPANDA REAGENTS LTD.
 
 
 
 
12.2.5
SHENZHEN BIOEASY BIOTECHNOLOGY, INC.
 
 
 
 
12.2.6
GOLD STANDARD DIAGNOSTICS
 
 
 
 
12.2.7
BIO-X DIAGNOSTICS S.A.
 
 
 
 
12.2.8
DEMEDITEC DIAGNOSTICS GMBH
 
 
 
 
12.2.9
EUROIMMUN MEDIZINISCHE LABORDIAGNOSTIKA AG
 
 
 
 
12.2.10
BIOSTONE ANIMAL HEALTH
 
 
13
APPENDIX
 
 
 
539
 
13.1
DISCUSSION GUIDE
 
 
 
 
13.2
KNOWLEDGESTORE: MARKETSANDMARKETS’ SUBSCRIPTION PORTAL
 
 
 
 
13.3
RELATED REPORTS
 
 
 
 
13.4
AUTHOR DETAILS
 
 
 
LIST OF TABLES
 
 
 
 
 
TABLE 1
STANDARD CURRENCY CONVERSION RATES (USD)
 
 
 
 
TABLE 2
VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET: ASSUMPTIONS ANALYSIS
 
 
 
 
TABLE 3
VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET: RISK ASSESSMENT ANALYSIS
 
 
 
 
TABLE 4
NUMBER OF US HOUSEHOLDS THAT OWN A PET IN 2024, BY ANIMAL TYPE (MILLIONS)
 
 
 
 
TABLE 5
ANIMAL DISEASE OUTBREAKS IN ASIA PACIFIC COUNTRIES (2009–2023)
 
 
 
 
TABLE 6
AVERAGE PREMIUMS PAID IN US, 2020 VS. 2023
 
 
 
 
TABLE 7
NORTH AMERICA: PET HEALTH INSURANCE MARKET (2012–2023) (USD MILLION)
 
 
 
 
TABLE 8
VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET: PORTER’S FIVE FORCES ANALYSIS
 
 
 
 
TABLE 9
NORTH AMERICA: REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
 
 
 
 
TABLE 10
EUROPE: REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
 
 
 
 
TABLE 11
REST OF THE WORLD: REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
 
 
 
 
TABLE 12
VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET: MAJOR PATENTS
 
 
 
 
TABLE 13
IMPORT DATA FOR HS CODE 9018, BY COUNTRY, 2020–2023 (USD THOUSAND)
 
 
 
 
TABLE 14
EXPORT DATA FOR HS CODE 901890, BY COUNTRY, 2020–2023 (USD THOUSAND)
 
 
 
 
TABLE 15
AVERAGE SELLING PRICE TREND OF KEY PLAYERS, BY PRODUCT, 2022–2024
 
 
 
 
TABLE 16
AVERAGE SELLING PRICE TREND OF ELISA TEST KITS (PER 96-WELL KIT), BY REGION, 2022–2024
 
 
 
 
TABLE 17
AVERAGE SELLING PRICE TREND OF LATERAL FLOW RAPID TESTS (PER UNIT), BY REGION, 2022–2024
 
 
 
 
TABLE 18
AVERAGE SELLING PRICE TREND OF PCR TEST KITS (VETERINARY PANELS), BY REGION, 2022–2024
 
 
 
 
TABLE 19
AVERAGE SELLING PRICE TREND OF IMMUNOASSAY ANALYZER (BENCHTOP), BY REGION, 2022–2024
 
 
 
 
TABLE 20
AVERAGE SELLING PRICE TREND OF HIGH-END IMMUNOASSAY ANALYZERS, BY REGION, 2022–2024
 
 
 
 
TABLE 21
AVERAGE SELLING PRICE TREND OF NUCLEIC ACID SEQUENCERS (BENCHTOP) BY REGION, 2022–2024
 
 
 
 
TABLE 22
VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET: KEY CONFERENCES & EVENTS, 2025–2026
 
 
 
 
TABLE 23
INFLUENCE OF STAKEHOLDERS ON BUYING PROCESS FOR VETERINARY INFECTIOUS DISEASE DIAGNOSTIC PRODUCTS (%)
 
 
 
 
TABLE 24
KEY BUYING CRITERIA FOR VETERINARY INFECTIOUS DISEASE DIAGNOSTIC PRODUCTS
 
 
 
 
TABLE 25
KEY COMPANIES IMPLEMENTING AI IN VETERINARY INFECTIOUS DISEASE DIAGNOSTICS
 
 
 
 
TABLE 26
VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET: ROLE OF COMPANIES IN ECOSYSTEM
 
 
 
 
TABLE 27
US-ADJUSTED RECIPROCAL TARIFF RATES
 
 
 
 
TABLE 28
KEY PRODUCT-RELATED TARIFFS EFFECTIVE FOR VETERINARY INFECTIOUS DISEASE DIAGNOSTIC PRODUCTS
 
 
 
 
TABLE 29
NORTH AMERICA: IMPACT ON CANADA DUE TO US TARIFFS
 
 
 
 
TABLE 30
EUROPE: IMPACT ON GERMANY AND UK DUE TO US TARIFFS
 
 
 
 
TABLE 31
ASIA PACIFIC: IMPACT ON CHINA, JAPAN, AND INDIA DUE TO US TARIFFS
 
 
 
 
TABLE 32
LATIN AMERICA: IMPACT ON MEXICO DUE TO US TARIFFS
 
 
 
 
TABLE 33
VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET, BY PRODUCT, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 34
VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET, BY COUNTRY, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 35
KEY PLAYERS OFFERING VETERINARY INFECTIOUS DISEASE DIAGNOSTIC CONSUMABLES
 
 
 
 
TABLE 36
VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET FOR CONSUMABLES, BY COUNTRY, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 37
KEY PLAYERS PROVIDING VETERINARY INFECTIOUS DISEASE DIAGNOSTIC INSTRUMENTS
 
 
 
 
TABLE 38
VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET FOR INSTRUMENTS, BY COUNTRY, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 39
VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET, BY TECHNOLOGY, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 40
KEY PLAYERS PROVIDING IMMUNODIAGNOSTIC TECHNOLOGIES
 
 
 
 
TABLE 41
VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET FOR IMMUNODIAGNOSTICS, BY TYPE, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 42
VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET FOR IMMUNODIAGNOSTICS, BY COUNTRY, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 43
KEY PLAYERS PROVIDING LATERAL FLOW ASSAYS
 
 
 
 
TABLE 44
VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET FOR LATERAL FLOW ASSAYS, BY REGION, 2023–2030 (THOUSAND UNITS)
 
 
 
 
TABLE 45
VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET FOR LATERAL FLOW ASSAYS, BY TYPE, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 46
VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET FOR LATERAL FLOW ASSAYS, BY COUNTRY, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 47
KEY PLAYERS PROVIDING LATERAL FLOW RAPID TESTS
 
 
 
 
TABLE 48
VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET FOR LATERAL FLOW RAPID TESTS, BY COUNTRY, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 49
KEY PLAYERS PROVIDING LATERAL FLOW STRIP READERS
 
 
 
 
TABLE 50
VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET FOR LATERAL FLOW STRIP READERS, BY COUNTRY, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 51
KEY PLAYERS PROVIDING ELISA TESTS
 
 
 
 
TABLE 52
VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET FOR ELISA TESTS, BY REGION, 2023–2030 (THOUSAND UNITS)
 
 
 
 
TABLE 53
VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET FOR ELISA TESTS, BY COUNTRY, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 54
KEY PLAYERS PROVIDING IMMUNOASSAY ANALYZERS
 
 
 
 
TABLE 55
VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET FOR IMMUNOASSAY ANALYZERS, BY REGION, 2023–2030 (THOUSAND UNITS)
 
 
 
 
TABLE 56
VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET FOR IMMUNOASSAY ANALYZERS, BY COUNTRY, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 57
KEY PLAYERS PROVIDING OTHER IMMUNODIAGNOSTIC TECHNOLOGIES
 
 
 
 
TABLE 58
VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET FOR OTHER IMMUNODIAGNOSTIC TECHNOLOGIES, BY COUNTRY, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 59
KEY PLAYERS PROVIDING MOLECULAR DIAGNOSTIC TESTS
 
 
 
 
TABLE 60
VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET FOR MOLECULAR DIAGNOSTICS, BY TYPE, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 61
VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET FOR MOLECULAR DIAGNOSTICS, BY COUNTRY, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 62
KEY PLAYERS PROVIDING PCR TESTS
 
 
 
 
TABLE 63
VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET FOR PCR TESTS, BY REGION, 2023–2030 (THOUSAND UNITS)
 
 
 
 
TABLE 64
VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET FOR PCR TESTS, BY COUNTRY, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 65
KEY PLAYERS PROVIDING NUCLEIC ACID SEQUENCING
 
 
 
 
TABLE 66
VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET FOR NUCLEIC ACID SEQUENCING, BY REGION, 2023–2030 (THOUSAND UNITS)
 
 
 
 
TABLE 67
VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET FOR NUCLEIC ACID SEQUENCING, BY COUNTRY, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 68
KEY PLAYERS PROVIDING MICROARRAYS
 
 
 
 
TABLE 69
VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET FOR MICROARRAYS, BY REGION, 2023–2030 (THOUSAND UNITS)
 
 
 
 
TABLE 70
VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET FOR MICROARRAYS, BY COUNTRY, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 71
KEY PLAYERS PROVIDING OTHER MOLECULAR DIAGNOSTIC TECHNOLOGIES
 
 
 
 
TABLE 72
VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET FOR OTHER MOLECULAR DIAGNOSTIC TECHNOLOGIES, BY COUNTRY, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 73
KEY PLAYERS PROVIDING OTHER TECHNOLOGIES
 
 
 
 
TABLE 74
VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET FOR OTHER TECHNOLOGIES, BY COUNTRY, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 75
VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET, BY ANIMAL TYPE, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 76
KEY PLAYERS PROVIDING VETERINARY DIAGNOSTIC TESTS FOR COMPANION ANIMALS
 
 
 
 
TABLE 77
VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET FOR COMPANION ANIMALS, BY COUNTRY, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 78
VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET FOR COMPANION ANIMALS, BY TYPE, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 79
KEY PLAYERS PROVIDING VETERINARY DIAGNOSTIC TESTS FOR DOGS
 
 
 
 
TABLE 80
VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET FOR DOGS, BY COUNTRY, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 81
KEY PLAYERS PROVIDING VETERINARY DIAGNOSTIC TESTS FOR CATS
 
 
 
 
TABLE 82
VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET FOR CATS, BY COUNTRY, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 83
KEY PLAYERS PROVIDING VETERINARY DIAGNOSTIC TESTS FOR HORSES
 
 
 
 
TABLE 84
VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET FOR HORSES, BY COUNTRY, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 85
KEY PLAYERS PROVIDING VETERINARY DIAGNOSTIC TESTS FOR OTHER COMPANION ANIMALS
 
 
 
 
TABLE 86
VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET FOR OTHER COMPANION ANIMALS, BY COUNTRY, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 87
VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET FOR COMPANION ANIMALS, BY TECHNOLOGY, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 88
KEY PLAYERS PROVIDING IMMUNODIAGNOSTIC TECHNOLOGIES FOR COMPANION ANIMALS
 
 
 
 
TABLE 89
COMPANION ANIMALS MARKET FOR IMMUNODIAGNOSTICS, BY TYPE, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 90
COMPANION ANIMALS MARKET FOR IMMUNODIAGNOSTICS, BY COUNTRY, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 91
KEY PLAYERS PROVIDING LATERAL FLOW ASSAYS FOR COMPANION ANIMALS
 
 
 
 
TABLE 92
COMPANION ANIMALS MARKET FOR LATERAL FLOW ASSAYS, BY COUNTRY, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 93
KEY PLAYERS PROVIDING ELISA TESTS FOR COMPANION ANIMALS
 
 
 
 
TABLE 94
COMPANION ANIMALS MARKET FOR ELISA TESTS, BY COUNTRY, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 95
KEY PLAYERS PROVIDING IMMUNOASSAY ANALYZERS FOR COMPANION ANIMALS
 
 
 
 
TABLE 96
COMPANION ANIMALS MARKET FOR IMMUNOASSAY ANALYZERS, BY COUNTRY, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 97
KEY PLAYERS PROVIDING OTHER IMMUNODIAGNOSTIC TECHNOLOGIES FOR COMPANION ANIMALS
 
 
 
 
TABLE 98
COMPANION ANIMALS MARKET FOR OTHER IMMUNODIAGNOSTIC TECHNOLOGIES, BY COUNTRY, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 99
KEY PLAYERS PROVIDING MOLECULAR DIAGNOSTICS FOR COMPANION ANIMALS
 
 
 
 
TABLE 100
COMPANION ANIMALS MARKET FOR MOLECULAR DIAGNOSTICS, BY TYPE, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 101
COMPANION ANIMALS MARKET FOR MOLECULAR DIAGNOSTICS, BY COUNTRY, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 102
KEY PLAYERS PROVIDING PCR TESTS FOR COMPANION ANIMALS
 
 
 
 
TABLE 103
COMPANION ANIMALS MARKET FOR PCR TESTS, BY COUNTRY, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 104
KEY PLAYERS PROVIDING NUCLEIC ACID SEQUENCING FOR COMPANION ANIMALS
 
 
 
 
TABLE 105
COMPANION ANIMALS MARKET FOR NUCLEIC ACID SEQUENCING, BY COUNTRY, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 106
KEY PLAYERS PROVIDING MICROARRAYS FOR COMPANION ANIMALS
 
 
 
 
TABLE 107
COMPANION ANIMALS MARKET FOR MICROARRAYS, BY COUNTRY, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 108
KEY PLAYERS PROVIDING OTHER MOLECULAR DIAGNOSTIC TECHNOLOGIES FOR COMPANION ANIMALS
 
 
 
 
TABLE 109
COMPANION ANIMALS MARKET FOR OTHER MOLECULAR DIAGNOSTIC TECHNOLOGIES, BY COUNTRY, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 110
KEY PLAYERS PROVIDING OTHER TECHNOLOGIES FOR COMPANION ANIMALS
 
 
 
 
TABLE 111
COMPANION ANIMALS MARKET FOR OTHER TECHNOLOGIES, BY COUNTRY, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 112
KEY PLAYERS PROVIDING VETERINARY DIAGNOSTIC TESTS FOR LIVESTOCK
 
 
 
 
TABLE 113
VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET FOR LIVESTOCK, BY COUNTRY, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 114
VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET FOR LIVESTOCK, BY TYPE, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 115
KEY PLAYERS PROVIDING VETERINARY DIAGNOSTIC TESTS FOR CATTLE
 
 
 
 
TABLE 116
VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET FOR CATTLE, BY COUNTRY, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 117
KEY PLAYERS PROVIDING VETERINARY DIAGNOSTIC TESTS FOR PIGS
 
 
 
 
TABLE 118
VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET FOR PIGS, BY COUNTRY, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 119
KEY PLAYERS PROVIDING VETERINARY DIAGNOSTIC TESTS FOR POULTRY
 
 
 
 
TABLE 120
VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET FOR POULTRY, BY COUNTRY, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 121
KEY PLAYERS PROVIDING VETERINARY DIAGNOSTIC TESTS FOR OTHER LIVESTOCK ANIMALS
 
 
 
 
TABLE 122
VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET FOR OTHER LIVESTOCK, BY COUNTRY, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 123
VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET FOR LIVESTOCK, BY TECHNOLOGY, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 124
KEY PLAYERS PROVIDING IMMUNODIAGNOSTIC TECHNOLOGIES FOR LIVESTOCK
 
 
 
 
TABLE 125
LIVESTOCK MARKET FOR IMMUNODIAGNOSTICS, BY TYPE, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 126
LIVESTOCK MARKET FOR IMMUNODIAGNOSTICS, BY COUNTRY, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 127
KEY PLAYERS PROVIDING LATERAL FLOW ASSAYS FOR LIVESTOCK
 
 
 
 
TABLE 128
LIVESTOCK MARKET FOR LATERAL FLOW ASSAYS, BY COUNTRY, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 129
KEY PLAYERS PROVIDING ELISA TESTS FOR LIVESTOCK
 
 
 
 
TABLE 130
LIVESTOCK MARKET FOR ELISA TESTS, BY COUNTRY, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 131
KEY PLAYERS PROVIDING IMMUNOASSAY ANALYZERS FOR LIVESTOCK
 
 
 
 
TABLE 132
LIVESTOCK MARKET FOR IMMUNOASSAY ANALYZERS, BY COUNTRY, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 133
KEY PLAYERS PROVIDING OTHER IMMUNODIAGNOSTIC TECHNOLOGIES FOR LIVESTOCK
 
 
 
 
TABLE 134
LIVESTOCK MARKET FOR OTHER IMMUNODIAGNOSTIC TECHNOLOGIES, BY COUNTRY, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 135
KEY PLAYERS PROVIDING MOLECULAR DIAGNOSTICS FOR LIVESTOCK
 
 
 
 
TABLE 136
LIVESTOCK MARKET FOR MOLECULAR DIAGNOSTICS, BY TYPE, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 137
LIVESTOCK MARKET FOR MOLECULAR DIAGNOSTICS, BY COUNTRY, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 138
KEY PLAYERS PROVIDING PCR TESTS FOR LIVESTOCK
 
 
 
 
TABLE 139
LIVESTOCK MARKET FOR PCR TESTS, BY COUNTRY, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 140
KEY PLAYERS PROVIDING NUCLEIC ACID SEQUENCING FOR LIVESTOCK
 
 
 
 
TABLE 141
LIVESTOCK MARKET FOR NUCLEIC ACID SEQUENCING, BY COUNTRY, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 142
KEY PLAYERS PROVIDING MICROARRAYS FOR LIVESTOCK
 
 
 
 
TABLE 143
LIVESTOCK MARKET FOR MICROARRAYS, BY COUNTRY, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 144
KEY PLAYERS PROVIDING OTHER MOLECULAR DIAGNOSTIC TECHNOLOGIES FOR LIVESTOCK
 
 
 
 
TABLE 145
LIVESTOCK MARKET FOR OTHER MOLECULAR DIAGNOSTIC TECHNOLOGIES, BY COUNTRY, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 146
KEY PLAYERS PROVIDING OTHER TECHNOLOGIES FOR LIVESTOCK
 
 
 
 
TABLE 147
LIVESTOCK MARKET FOR OTHER TECHNOLOGIES, BY COUNTRY, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 148
VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET, BY END USER, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 149
VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET FOR VETERINARY REFERENCE LABORATORIES, BY COUNTRY, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 150
BASIC ANNUAL EXPENSES FOR CATS & DOGS IN US, 2023 (USD)
 
 
 
 
TABLE 151
VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET FOR VETERINARY HOSPITALS & CLINICS, BY COUNTRY, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 152
VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET FOR POC/IN-HOUSE TESTING, BY COUNTRY, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 153
VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET FOR VETERINARY RESEARCH INSTITUTES & UNIVERSITIES, BY COUNTRY, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 154
VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET, BY REGION, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 155
NORTH AMERICA: VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET, BY COUNTRY, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 156
NORTH AMERICA: VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET, BY PRODUCT, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 157
NORTH AMERICA: VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET, BY TECHNOLOGY, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 158
NORTH AMERICA: VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET FOR IMMUNODIAGNOSTICS, BY TYPE, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 159
NORTH AMERICA: VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET FOR LATERAL FLOW ASSAYS, BY TYPE, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 160
NORTH AMERICA: VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET FOR MOLECULAR DIAGNOSTICS, BY TYPE, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 161
NORTH AMERICA: VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET, BY ANIMAL TYPE, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 162
NORTH AMERICA: VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET FOR COMPANION ANIMALS, BY TYPE, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 163
NORTH AMERICA: VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET FOR COMPANION ANIMALS, BY TECHNOLOGY, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 164
NORTH AMERICA: COMPANION ANIMALS MARKET FOR IMMUNODIAGNOSTICS, BY TYPE, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 165
NORTH AMERICA: COMPANION ANIMALS MARKET FOR MOLECULAR DIAGNOSTICS, BY TYPE, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 166
NORTH AMERICA: VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET FOR LIVESTOCK, BY TYPE, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 167
NORTH AMERICA: VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET FOR LIVESTOCK, BY TECHNOLOGY, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 168
NORTH AMERICA: LIVESTOCK MARKET FOR IMMUNODIAGNOSTICS, BY TYPE, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 169
NORTH AMERICA: LIVESTOCK MARKET FOR MOLECULAR DIAGNOSTICS, BY TYPE, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 170
NORTH AMERICA: VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET, BY END USER, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 171
US: KEY MACROINDICATORS
 
 
 
 
TABLE 172
US: VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET, BY PRODUCT, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 173
US: VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET, BY TECHNOLOGY, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 174
US: VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET FOR IMMUNODIAGNOSTICS, BY TYPE, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 175
US: VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET FOR LATERAL FLOW ASSAYS, BY TYPE, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 176
US: VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET FOR MOLECULAR DIAGNOSTICS, BY TYPE, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 177
US: VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET, BY ANIMAL TYPE, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 178
US: VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET FOR COMPANION ANIMALS, BY TYPE, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 179
US: VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET FOR COMPANION ANIMALS, BY TECHNOLOGY, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 180
US: COMPANION ANIMALS MARKET FOR IMMUNODIAGNOSTICS, BY TYPE, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 181
US: COMPANION ANIMALS MARKET FOR MOLECULAR DIAGNOSTICS, BY TYPE, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 182
US: VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET FOR LIVESTOCK, BY TYPE, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 183
US: VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET FOR LIVESTOCK, BY TECHNOLOGY, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 184
US: LIVESTOCK MARKET FOR IMMUNODIAGNOSTICS, BY TYPE, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 185
US: LIVESTOCK MARKET FOR MOLECULAR DIAGNOSTICS, BY TYPE, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 186
US: VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET, BY END USER, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 187
CANADA: KEY MACROINDICATORS
 
 
 
 
TABLE 188
CANADA: VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET, BY PRODUCT, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 189
CANADA: VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET, BY TECHNOLOGY, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 190
CANADA: VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET FOR IMMUNODIAGNOSTICS, BY TYPE, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 191
CANADA: VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET FOR LATERAL FLOW ASSAYS, BY TYPE, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 192
CANADA: VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET FOR MOLECULAR DIAGNOSTICS, BY TYPE, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 193
CANADA: VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET, BY ANIMAL TYPE, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 194
CANADA: VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET FOR COMPANION ANIMALS, BY TYPE, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 195
CANADA: VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET FOR COMPANION ANIMALS, BY TECHNOLOGY, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 196
CANADA: COMPANION ANIMALS MARKET FOR IMMUNODIAGNOSTICS, BY TYPE, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 197
CANADA: COMPANION ANIMALS MARKET FOR MOLECULAR DIAGNOSTICS, BY TYPE, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 198
CANADA: VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET FOR LIVESTOCK, BY TYPE, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 199
CANADA: VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET FOR LIVESTOCK, BY TECHNOLOGY, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 200
CANADA: LIVESTOCK MARKET FOR IMMUNODIAGNOSTICS, BY TYPE, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 201
CANADA: LIVESTOCK MARKET FOR MOLECULAR DIAGNOSTICS, BY TYPE, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 202
CANADA: VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET, BY END USER, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 203
EUROPE: VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET, BY COUNTRY, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 204
EUROPE: VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET, BY PRODUCT, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 205
EUROPE: VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET, BY TECHNOLOGY, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 206
EUROPE: VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET FOR IMMUNODIAGNOSTICS, BY TYPE, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 207
EUROPE: VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET FOR LATERAL FLOW ASSAYS, BY TYPE, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 208
EUROPE: VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET FOR MOLECULAR DIAGNOSTICS, BY TYPE, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 209
EUROPE: VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET, BY ANIMAL TYPE, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 210
EUROPE: VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET FOR COMPANION ANIMALS, BY TYPE, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 211
EUROPE: VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET FOR COMPANION ANIMALS, BY TECHNOLOGY, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 212
EUROPE: COMPANION ANIMALS MARKET FOR IMMUNODIAGNOSTICS, BY TYPE, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 213
EUROPE: COMPANION ANIMALS MARKET FOR MOLECULAR DIAGNOSTICS, BY TYPE, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 214
EUROPE: VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET FOR LIVESTOCK, BY TYPE, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 215
EUROPE: VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET FOR LIVESTOCK, BY TECHNOLOGY, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 216
EUROPE: LIVESTOCK MARKET FOR IMMUNODIAGNOSTICS, BY TYPE, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 217
EUROPE: LIVESTOCK MARKET FOR MOLECULAR DIAGNOSTICS, BY TYPE, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 218
EUROPE: VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET, BY END USER, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 219
GERMANY: KEY MACROINDICATORS
 
 
 
 
TABLE 220
GERMANY: VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET, BY PRODUCT, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 221
GERMANY: VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET, BY TECHNOLOGY, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 222
GERMANY: VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET FOR IMMUNODIAGNOSTICS, BY TYPE, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 223
GERMANY: VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET FOR LATERAL FLOW ASSAYS, BY TYPE, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 224
GERMANY: VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET FOR MOLECULAR DIAGNOSTICS, BY TYPE, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 225
GERMANY: VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET, BY ANIMAL TYPE, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 226
GERMANY: VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET FOR COMPANION ANIMALS, BY TYPE, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 227
GERMANY: VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET FOR COMPANION ANIMALS, BY TECHNOLOGY, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 228
GERMANY: COMPANION ANIMALS MARKET FOR IMMUNODIAGNOSTICS, BY TYPE, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 229
GERMANY: COMPANION ANIMALS MARKET FOR MOLECULAR DIAGNOSTICS, BY TYPE, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 230
GERMANY: VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET FOR LIVESTOCK, BY TYPE, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 231
GERMANY: VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET FOR LIVESTOCK, BY TECHNOLOGY, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 232
GERMANY: LIVESTOCK MARKET FOR IMMUNODIAGNOSTICS, BY TYPE, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 233
GERMANY: LIVESTOCK MARKET FOR MOLECULAR DIAGNOSTICS, BY TYPE, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 234
GERMANY: VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET, BY END USER, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 235
UK: KEY MACROINDICATORS
 
 
 
 
TABLE 236
UK: VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET, BY PRODUCT, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 237
UK: VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET, BY TECHNOLOGY, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 238
UK: VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET FOR IMMUNODIAGNOSTICS, BY TYPE, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 239
UK: VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET FOR LATERAL FLOW ASSAYS, BY TYPE, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 240
UK: VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET FOR MOLECULAR DIAGNOSTICS, BY TYPE, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 241
UK: VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET, BY ANIMAL TYPE, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 242
UK: VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET FOR COMPANION ANIMALS, BY TYPE, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 243
UK: VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET FOR COMPANION ANIMALS, BY TECHNOLOGY, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 244
UK: COMPANION ANIMALS MARKET FOR IMMUNODIAGNOSTICS, BY TYPE, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 245
UK: COMPANION ANIMALS MARKET FOR MOLECULAR DIAGNOSTICS, BY TYPE, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 246
UK: VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET FOR LIVESTOCK, BY TYPE, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 247
UK: VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET FOR LIVESTOCK, BY TECHNOLOGY, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 248
UK: LIVESTOCK MARKET FOR IMMUNODIAGNOSTICS, BY TYPE, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 249
UK: LIVESTOCK MARKET FOR MOLECULAR DIAGNOSTICS, BY TYPE, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 250
UK: VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET, BY END USER, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 251
FRANCE: KEY MACROINDICATORS
 
 
 
 
TABLE 252
FRANCE: VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET, BY PRODUCT, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 253
FRANCE: VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET, BY TECHNOLOGY, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 254
FRANCE: VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET FOR IMMUNODIAGNOSTICS, BY TYPE, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 255
FRANCE: VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET FOR LATERAL FLOW ASSAYS, BY TYPE, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 256
FRANCE: VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET FOR MOLECULAR DIAGNOSTICS, BY TYPE, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 257
FRANCE: VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET, BY ANIMAL TYPE, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 258
FRANCE: VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET FOR COMPANION ANIMALS, BY TYPE, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 259
FRANCE: VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET FOR COMPANION ANIMALS, BY TECHNOLOGY, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 260
FRANCE: COMPANION ANIMALS MARKET FOR IMMUNODIAGNOSTICS, BY TYPE, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 261
FRANCE: COMPANION ANIMALS MARKET FOR MOLECULAR DIAGNOSTICS, BY TYPE, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 262
FRANCE: VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET FOR LIVESTOCK, BY TYPE, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 263
FRANCE: VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET FOR LIVESTOCK, BY TECHNOLOGY, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 264
FRANCE: LIVESTOCK MARKET FOR IMMUNODIAGNOSTICS, BY TYPE, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 265
FRANCE: LIVESTOCK MARKET FOR MOLECULAR DIAGNOSTICS, BY TYPE, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 266
FRANCE: VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET, BY END USER, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 267
ITALY: KEY MACROINDICATORS
 
 
 
 
TABLE 268
ITALY: VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET, BY PRODUCT, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 269
ITALY: VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET, BY TECHNOLOGY, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 270
ITALY: VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET FOR IMMUNODIAGNOSTICS, BY TYPE, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 271
ITALY: VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET FOR LATERAL FLOW ASSAYS, BY TYPE, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 272
ITALY: VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET FOR MOLECULAR DIAGNOSTICS, BY TYPE, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 273
ITALY: VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET, BY ANIMAL TYPE, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 274
ITALY: VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET FOR COMPANION ANIMALS, BY TYPE, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 275
ITALY: VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET FOR COMPANION ANIMALS, BY TECHNOLOGY, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 276
ITALY: COMPANION ANIMALS MARKET FOR IMMUNODIAGNOSTICS, BY TYPE, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 277
ITALY: COMPANION ANIMALS MARKET FOR MOLECULAR DIAGNOSTICS, BY TYPE, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 278
ITALY: VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET FOR LIVESTOCK, BY TYPE, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 279
ITALY: VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET FOR LIVESTOCK, BY TECHNOLOGY, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 280
ITALY: LIVESTOCK MARKET FOR IMMUNODIAGNOSTICS, BY TYPE, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 281
ITALY: LIVESTOCK MARKET FOR MOLECULAR DIAGNOSTICS, BY TYPE, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 282
ITALY: VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET, BY END USER, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 283
SPAIN: KEY MACROINDICATORS
 
 
 
 
TABLE 284
SPAIN: VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET, BY PRODUCT, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 285
SPAIN: VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET, BY TECHNOLOGY, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 286
SPAIN: VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET FOR IMMUNODIAGNOSTICS, BY TYPE, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 287
SPAIN: VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET FOR LATERAL FLOW ASSAYS, BY TYPE, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 288
SPAIN: VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET FOR MOLECULAR DIAGNOSTICS, BY TYPE, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 289
SPAIN: VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET, BY ANIMAL TYPE, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 290
SPAIN: VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET FOR COMPANION ANIMALS, BY TYPE, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 291
SPAIN: VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET FOR COMPANION ANIMALS, BY TECHNOLOGY, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 292
SPAIN: COMPANION ANIMALS MARKET FOR IMMUNODIAGNOSTICS, BY TYPE, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 293
SPAIN: COMPANION ANIMALS MARKET FOR MOLECULAR DIAGNOSTICS, BY TYPE, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 294
SPAIN: VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET FOR LIVESTOCK, BY TYPE, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 295
SPAIN: VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET FOR LIVESTOCK, BY TECHNOLOGY, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 296
SPAIN: LIVESTOCK MARKET FOR IMMUNODIAGNOSTICS, BY TYPE, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 297
SPAIN: LIVESTOCK MARKET FOR MOLECULAR DIAGNOSTICS, BY TYPE, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 298
SPAIN: VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET, BY END USER, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 299
NETHERLANDS: KEY MACROINDICATORS
 
 
 
 
TABLE 300
NETHERLANDS: VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET, BY PRODUCT, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 301
NETHERLANDS: VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET, BY TECHNOLOGY, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 302
NETHERLANDS: VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET FOR IMMUNODIAGNOSTICS, BY TYPE, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 303
NETHERLANDS: VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET FOR LATERAL FLOW ASSAYS, BY TYPE, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 304
NETHERLANDS: VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET FOR MOLECULAR DIAGNOSTICS, BY TYPE, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 305
NETHERLANDS: VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET, BY ANIMAL TYPE, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 306
NETHERLANDS: VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET FOR COMPANION ANIMALS, BY TYPE, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 307
NETHERLANDS: VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET FOR COMPANION ANIMALS, BY TECHNOLOGY, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 308
NETHERLANDS: COMPANION ANIMALS MARKET FOR IMMUNODIAGNOSTICS, BY TYPE, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 309
NETHERLANDS: COMPANION ANIMALS MARKET FOR MOLECULAR DIAGNOSTICS, BY TYPE, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 310
NETHERLANDS: VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET FOR LIVESTOCK, BY TYPE, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 311
NETHERLANDS: VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET FOR LIVESTOCK, BY TECHNOLOGY, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 312
NETHERLANDS: LIVESTOCK MARKET FOR IMMUNODIAGNOSTICS, BY TYPE, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 313
NETHERLANDS: LIVESTOCK MARKET FOR MOLECULAR DIAGNOSTICS, BY TYPE, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 314
NETHERLANDS: VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET, BY END USER, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 315
REST OF EUROPE: VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET, BY PRODUCT, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 316
REST OF EUROPE: VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET, BY TECHNOLOGY, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 317
REST OF EUROPE: VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET FOR IMMUNODIAGNOSTICS, BY TYPE, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 318
REST OF EUROPE: VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET FOR LATERAL FLOW ASSAYS, BY TYPE, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 319
REST OF EUROPE: VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET FOR MOLECULAR DIAGNOSTICS, BY TYPE, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 320
REST OF EUROPE: VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET, BY ANIMAL TYPE, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 321
REST OF EUROPE: VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET FOR COMPANION ANIMALS, BY TYPE, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 322
REST OF EUROPE: VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET FOR COMPANION ANIMALS, BY TECHNOLOGY, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 323
REST OF EUROPE: COMPANION ANIMALS MARKET FOR IMMUNODIAGNOSTICS, BY TYPE, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 324
REST OF EUROPE: COMPANION ANIMALS MARKET FOR MOLECULAR DIAGNOSTICS, BY TYPE, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 325
REST OF EUROPE: VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET FOR LIVESTOCK, BY TYPE, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 326
REST OF EUROPE: VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET FOR LIVESTOCK, BY TECHNOLOGY, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 327
REST OF EUROPE: LIVESTOCK MARKET FOR IMMUNODIAGNOSTICS, BY TYPE, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 328
REST OF EUROPE: LIVESTOCK MARKET FOR MOLECULAR DIAGNOSTICS, BY TYPE, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 329
REST OF EUROPE: VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET, BY END USER, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 330
ASIA PACIFIC: VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET, BY COUNTRY, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 331
ASIA PACIFIC: VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET, BY PRODUCT, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 332
ASIA PACIFIC: VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET, BY TECHNOLOGY, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 333
ASIA PACIFIC: VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET FOR IMMUNODIAGNOSTICS, BY TYPE, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 334
ASIA PACIFIC: VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET FOR LATERAL FLOW ASSAYS, BY TYPE, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 335
ASIA PACIFIC: VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET FOR MOLECULAR DIAGNOSTICS, BY TYPE, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 336
ASIA PACIFIC: VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET, BY ANIMAL TYPE, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 337
ASIA PACIFIC: VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET FOR COMPANION ANIMALS, BY TYPE, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 338
ASIA PACIFIC: VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET FOR COMPANION ANIMALS, BY TECHNOLOGY, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 339
ASIA PACIFIC: COMPANION ANIMALS MARKET FOR IMMUNODIAGNOSTICS, BY TYPE, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 340
ASIA PACIFIC: COMPANION ANIMALS MARKET FOR MOLECULAR DIAGNOSTICS, BY TYPE, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 341
ASIA PACIFIC: VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET FOR LIVESTOCK, BY TYPE, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 342
ASIA PACIFIC: VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET FOR LIVESTOCK, BY TECHNOLOGY, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 343
ASIA PACIFIC: LIVESTOCK MARKET FOR IMMUNODIAGNOSTICS, BY TYPE, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 344
ASIA PACIFIC: LIVESTOCK MARKET FOR MOLECULAR DIAGNOSTICS, BY TYPE, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 345
ASIA PACIFIC: VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET, BY END USER, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 346
CHINA: KEY MACROINDICATORS
 
 
 
 
TABLE 347
CHINA: VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET, BY PRODUCT, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 348
CHINA: VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET, BY TECHNOLOGY, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 349
CHINA: VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET FOR IMMUNODIAGNOSTICS, BY TYPE, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 350
CHINA: VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET FOR LATERAL FLOW ASSAYS, BY TYPE, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 351
CHINA: VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET FOR MOLECULAR DIAGNOSTICS, BY TYPE, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 352
CHINA: VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET, BY ANIMAL TYPE, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 353
CHINA: VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET FOR COMPANION ANIMALS, BY TYPE, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 354
CHINA: VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET FOR COMPANION ANIMALS, BY TECHNOLOGY, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 355
CHINA: COMPANION ANIMALS MARKET FOR IMMUNODIAGNOSTICS, BY TYPE, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 356
CHINA: COMPANION ANIMALS MARKET FOR MOLECULAR DIAGNOSTICS, BY TYPE, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 357
CHINA: VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET FOR LIVESTOCK, BY TYPE, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 358
CHINA: VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET FOR LIVESTOCK, BY TECHNOLOGY, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 359
CHINA: LIVESTOCK MARKET FOR IMMUNODIAGNOSTICS, BY TYPE, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 360
CHINA: LIVESTOCK MARKET FOR MOLECULAR DIAGNOSTICS, BY TYPE, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 361
CHINA: VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET, BY END USER, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 362
JAPAN: KEY MACROINDICATORS
 
 
 
 
TABLE 363
JAPAN: VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET, BY PRODUCT, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 364
JAPAN: VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET, BY TECHNOLOGY, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 365
JAPAN: VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET FOR IMMUNODIAGNOSTICS, BY TYPE, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 366
JAPAN: VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET FOR LATERAL FLOW ASSAYS, BY TYPE, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 367
JAPAN: VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET FOR MOLECULAR DIAGNOSTICS, BY TYPE, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 368
JAPAN: VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET, BY ANIMAL TYPE, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 369
JAPAN: VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET FOR COMPANION ANIMALS, BY TYPE, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 370
JAPAN: VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET FOR COMPANION ANIMALS, BY TECHNOLOGY, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 371
JAPAN: COMPANION ANIMALS MARKET FOR IMMUNODIAGNOSTICS, BY TYPE, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 372
JAPAN: COMPANION ANIMALS MARKET FOR MOLECULAR DIAGNOSTICS, BY TYPE, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 373
JAPAN: VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET FOR LIVESTOCK, BY TYPE, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 374
JAPAN: VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET FOR LIVESTOCK, BY TECHNOLOGY, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 375
JAPAN: LIVESTOCK MARKET FOR IMMUNODIAGNOSTICS, BY TYPE, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 376
JAPAN: LIVESTOCK MARKET FOR MOLECULAR DIAGNOSTICS, BY TYPE, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 377
JAPAN: VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET, BY END USER, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 378
INDIA: PRODUCTION AND CONSUMPTION OF ANIMAL-DERIVED FOOD PRODUCTS, 2000 VS. 2030 (THOUSAND METRIC TONS)
 
 
 
 
TABLE 379
INDIA: KEY MACROINDICATORS
 
 
 
 
TABLE 380
INDIA: VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET, BY PRODUCT, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 381
INDIA: VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET, BY TECHNOLOGY, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 382
INDIA: VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET FOR IMMUNODIAGNOSTICS, BY TYPE, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 383
INDIA: VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET FOR LATERAL FLOW ASSAYS, BY TYPE, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 384
INDIA: VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET FOR MOLECULAR DIAGNOSTICS, BY TYPE, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 385
INDIA: VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET, BY ANIMAL TYPE, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 386
INDIA: VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET FOR COMPANION ANIMALS, BY TYPE, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 387
INDIA: VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET FOR COMPANION ANIMALS, BY TECHNOLOGY, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 388
INDIA: COMPANION ANIMALS MARKET FOR IMMUNODIAGNOSTICS, BY TYPE, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 389
INDIA: COMPANION ANIMALS MARKET FOR MOLECULAR DIAGNOSTICS, BY TYPE, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 390
INDIA: VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET FOR LIVESTOCK, BY TYPE, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 391
INDIA: VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET FOR LIVESTOCK, BY TECHNOLOGY, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 392
INDIA: LIVESTOCK MARKET FOR IMMUNODIAGNOSTICS, BY TYPE, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 393
INDIA: LIVESTOCK MARKET FOR MOLECULAR DIAGNOSTICS, BY TYPE, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 394
INDIA: VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET, BY END USER, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 395
AUSTRALIA: KEY MACROINDICATORS
 
 
 
 
TABLE 396
AUSTRALIA: VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET, BY PRODUCT, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 397
AUSTRALIA: VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET, BY TECHNOLOGY, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 398
AUSTRALIA: VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET FOR IMMUNODIAGNOSTICS, BY TYPE, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 399
AUSTRALIA: VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET FOR LATERAL FLOW ASSAYS, BY TYPE, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 400
AUSTRALIA: VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET FOR MOLECULAR DIAGNOSTICS, BY TYPE, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 401
AUSTRALIA: VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET, BY ANIMAL TYPE, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 402
AUSTRALIA: VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET FOR COMPANION ANIMALS, BY TYPE, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 403
AUSTRALIA: VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET FOR COMPANION ANIMALS, BY TECHNOLOGY, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 404
AUSTRALIA: COMPANION ANIMALS MARKET FOR IMMUNODIAGNOSTICS, BY TYPE, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 405
AUSTRALIA: COMPANION ANIMALS MARKET FOR MOLECULAR DIAGNOSTICS, BY TYPE, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 406
AUSTRALIA: VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET FOR LIVESTOCK, BY TYPE, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 407
AUSTRALIA: VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET FOR LIVESTOCK, BY TECHNOLOGY, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 408
AUSTRALIA: LIVESTOCK MARKET FOR IMMUNODIAGNOSTICS, BY TYPE, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 409
AUSTRALIA: LIVESTOCK MARKET FOR MOLECULAR DIAGNOSTICS, BY TYPE, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 410
AUSTRALIA: VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET, BY END USER, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 411
SOUTH KOREA: KEY MACROINDICATORS
 
 
 
 
TABLE 412
SOUTH KOREA: VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET, BY PRODUCT, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 413
SOUTH KOREA: VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET, BY TECHNOLOGY, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 414
SOUTH KOREA: VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET FOR IMMUNODIAGNOSTICS, BY TYPE, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 415
SOUTH KOREA: VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET FOR LATERAL FLOW ASSAYS, BY TYPE, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 416
SOUTH KOREA: VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET FOR MOLECULAR DIAGNOSTICS, BY TYPE, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 417
SOUTH KOREA: VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET, BY ANIMAL TYPE, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 418
SOUTH KOREA: VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET FOR COMPANION ANIMALS, BY TYPE, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 419
SOUTH KOREA: VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET FOR COMPANION ANIMALS, BY TECHNOLOGY, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 420
SOUTH KOREA: COMPANION ANIMALS MARKET FOR IMMUNODIAGNOSTICS, BY TYPE, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 421
SOUTH KOREA: COMPANION ANIMALS MARKET FOR MOLECULAR DIAGNOSTICS, BY TYPE, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 422
SOUTH KOREA: VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET FOR LIVESTOCK, BY TYPE, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 423
SOUTH KOREA: VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET FOR LIVESTOCK, BY TECHNOLOGY, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 424
SOUTH KOREA: LIVESTOCK MARKET FOR IMMUNODIAGNOSTICS, BY TYPE, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 425
SOUTH KOREA: LIVESTOCK MARKET FOR MOLECULAR DIAGNOSTICS, BY TYPE, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 426
SOUTH KOREA: VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET, BY END USER, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 427
NEW ZEALAND: KEY MACROINDICATORS
 
 
 
 
TABLE 428
NEW ZEALAND: VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET, BY PRODUCT, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 429
NEW ZEALAND: VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET, BY TECHNOLOGY, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 430
NEW ZEALAND: VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET FOR IMMUNODIAGNOSTICS, BY TYPE, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 431
NEW ZEALAND: VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET FOR LATERAL FLOW ASSAYS, BY TYPE, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 432
NEW ZEALAND: VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET FOR MOLECULAR DIAGNOSTICS, BY TYPE, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 433
NEW ZEALAND: VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET, BY ANIMAL TYPE, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 434
NEW ZEALAND: VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET FOR COMPANION ANIMALS, BY TYPE, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 435
NEW ZEALAND: VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET FOR COMPANION ANIMALS, BY TECHNOLOGY, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 436
NEW ZEALAND: COMPANION ANIMALS MARKET FOR IMMUNODIAGNOSTICS, BY TYPE, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 437
NEW ZEALAND: COMPANION ANIMALS MARKET FOR MOLECULAR DIAGNOSTICS, BY TYPE, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 438
NEW ZEALAND: VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET FOR LIVESTOCK, BY TYPE, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 439
NEW ZEALAND: VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET FOR LIVESTOCK, BY TECHNOLOGY, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 440
NEW ZEALAND: LIVESTOCK MARKET FOR IMMUNODIAGNOSTICS, BY TYPE, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 441
NEW ZEALAND: LIVESTOCK MARKET FOR MOLECULAR DIAGNOSTICS, BY TYPE, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 442
NEW ZEALAND: VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET, BY END USER, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 443
VIETNAM: KEY MACROINDICATORS
 
 
 
 
TABLE 444
VIETNAM: VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET, BY PRODUCT, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 445
VIETNAM: VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET, BY TECHNOLOGY, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 446
VIETNAM: VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET FOR IMMUNODIAGNOSTICS, BY TYPE, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 447
VIETNAM: VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET FOR LATERAL FLOW ASSAYS, BY TYPE, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 448
VIETNAM: VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET FOR MOLECULAR DIAGNOSTICS, BY TYPE, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 449
VIETNAM: VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET, BY ANIMAL TYPE, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 450
VIETNAM: VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET FOR COMPANION ANIMALS, BY TYPE, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 451
VIETNAM: VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET FOR COMPANION ANIMALS, BY TECHNOLOGY, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 452
VIETNAM: COMPANION ANIMALS MARKET FOR IMMUNODIAGNOSTICS, BY TYPE, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 453
VIETNAM: COMPANION ANIMALS MARKET FOR MOLECULAR DIAGNOSTICS, BY TYPE, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 454
VIETNAM: VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET FOR LIVESTOCK, BY TYPE, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 455
VIETNAM: VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET FOR LIVESTOCK, BY TECHNOLOGY, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 456
VIETNAM: LIVESTOCK MARKET FOR IMMUNODIAGNOSTICS, BY TYPE, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 457
VIETNAM: LIVESTOCK MARKET FOR MOLECULAR DIAGNOSTICS, BY TYPE, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 458
VIETNAM: VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET, BY END USER, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 459
REST OF ASIA PACIFIC: VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET, BY PRODUCT, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 460
REST OF ASIA PACIFIC: VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET, BY TECHNOLOGY, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 461
REST OF ASIA PACIFIC: VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET FOR IMMUNODIAGNOSTICS, BY TYPE, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 462
REST OF ASIA PACIFIC: VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET FOR LATERAL FLOW ASSAYS, BY TYPE, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 463
REST OF ASIA PACIFIC: VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET FOR MOLECULAR DIAGNOSTICS, BY TYPE, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 464
REST OF ASIA PACIFIC: VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET, BY ANIMAL TYPE, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 465
REST OF ASIA PACIFIC: VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET FOR COMPANION ANIMALS, BY TYPE, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 466
REST OF ASIA PACIFIC: VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET FOR COMPANION ANIMALS, BY TECHNOLOGY, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 467
REST OF ASIA PACIFIC: COMPANION ANIMALS MARKET FOR IMMUNODIAGNOSTICS, BY TYPE, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 468
REST OF ASIA PACIFIC: COMPANION ANIMALS MARKET FOR MOLECULAR DIAGNOSTICS, BY TYPE, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 469
REST OF ASIA PACIFIC: VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET FOR LIVESTOCK, BY TYPE, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 470
REST OF ASIA PACIFIC: VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET FOR LIVESTOCK, BY TECHNOLOGY, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 471
REST OF ASIA PACIFIC: LIVESTOCK MARKET FOR IMMUNODIAGNOSTICS, BY TYPE, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 472
REST OF ASIA PACIFIC: LIVESTOCK MARKET FOR MOLECULAR DIAGNOSTICS, BY TYPE, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 473
REST OF ASIA PACIFIC: VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET, BY END USER, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 474
LATIN AMERICA: VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET, BY COUNTRY, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 475
LATIN AMERICA: VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET, BY PRODUCT, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 476
LATIN AMERICA: VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET, BY TECHNOLOGY, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 477
LATIN AMERICA: VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET FOR IMMUNODIAGNOSTICS, BY TYPE, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 478
LATIN AMERICA: VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET FOR LATERAL FLOW ASSAYS, BY TYPE, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 479
LATIN AMERICA: VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET FOR MOLECULAR DIAGNOSTICS, BY TYPE, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 480
LATIN AMERICA: VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET, BY ANIMAL TYPE, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 481
LATIN AMERICA: VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET FOR COMPANION ANIMALS, BY TYPE, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 482
LATIN AMERICA: VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET FOR COMPANION ANIMALS, BY TECHNOLOGY, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 483
LATIN AMERICA: COMPANION ANIMALS MARKET FOR IMMUNODIAGNOSTICS, BY TYPE, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 484
LATIN AMERICA: COMPANION ANIMALS MARKET FOR MOLECULAR DIAGNOSTICS, BY TYPE, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 485
LATIN AMERICA: VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET FOR LIVESTOCK, BY TYPE, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 486
LATIN AMERICA: VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET FOR LIVESTOCK, BY TECHNOLOGY, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 487
LATIN AMERICA: LIVESTOCK MARKET FOR IMMUNODIAGNOSTICS, BY TYPE, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 488
LATIN AMERICA: LIVESTOCK MARKET FOR MOLECULAR DIAGNOSTICS, BY TYPE, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 489
LATIN AMERICA: VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET, BY END USER, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 490
BRAZIL: KEY MACROINDICATORS
 
 
 
 
TABLE 491
BRAZIL: VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET, BY PRODUCT, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 492
BRAZIL: VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET, BY TECHNOLOGY, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 493
BRAZIL: VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET FOR IMMUNODIAGNOSTICS, BY TYPE, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 494
BRAZIL: VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET FOR LATERAL FLOW ASSAYS, BY TYPE, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 495
BRAZIL: VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET FOR MOLECULAR DIAGNOSTICS, BY TYPE, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 496
BRAZIL: VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET, BY ANIMAL TYPE, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 497
BRAZIL: VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET FOR COMPANION ANIMALS, BY TYPE, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 498
BRAZIL: VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET FOR COMPANION ANIMALS, BY TECHNOLOGY, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 499
BRAZIL: COMPANION ANIMALS MARKET FOR IMMUNODIAGNOSTICS, BY TYPE, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 500
BRAZIL: COMPANION ANIMALS MARKET FOR MOLECULAR DIAGNOSTICS, BY TYPE, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 501
BRAZIL: VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET FOR LIVESTOCK, BY TYPE, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 502
BRAZIL: VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET FOR LIVESTOCK, BY TECHNOLOGY, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 503
BRAZIL: LIVESTOCK MARKET FOR IMMUNODIAGNOSTICS, BY TYPE, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 504
BRAZIL: LIVESTOCK MARKET FOR MOLECULAR DIAGNOSTICS, BY TYPE, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 505
BRAZIL: VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET, BY END USER, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 506
MEXICO: KEY MACROINDICATORS
 
 
 
 
TABLE 507
MEXICO: VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET, BY PRODUCT, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 508
MEXICO: VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET, BY TECHNOLOGY, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 509
MEXICO: VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET FOR IMMUNODIAGNOSTICS, BY TYPE, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 510
MEXICO: VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET FOR LATERAL FLOW ASSAYS, BY TYPE, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 511
MEXICO: VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET FOR MOLECULAR DIAGNOSTICS, BY TYPE, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 512
MEXICO: VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET, BY ANIMAL TYPE, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 513
MEXICO: VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET FOR COMPANION ANIMALS, BY TYPE, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 514
MEXICO: VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET FOR COMPANION ANIMALS, BY TECHNOLOGY, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 515
MEXICO: COMPANION ANIMALS MARKET FOR IMMUNODIAGNOSTICS, BY TYPE, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 516
MEXICO: COMPANION ANIMALS MARKET FOR MOLECULAR DIAGNOSTICS, BY TYPE, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 517
MEXICO: VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET FOR LIVESTOCK, BY TYPE, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 518
MEXICO: VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET FOR LIVESTOCK, BY TECHNOLOGY, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 519
MEXICO: LIVESTOCK MARKET FOR IMMUNODIAGNOSTICS, BY TYPE, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 520
MEXICO: LIVESTOCK MARKET FOR MOLECULAR DIAGNOSTICS, BY TYPE, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 521
MEXICO: VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET, BY END USER, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 522
REST OF LATIN AMERICA: VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET, BY PRODUCT, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 523
REST OF LATIN AMERICA: VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET, BY TECHNOLOGY, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 524
REST OF LATIN AMERICA: VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET FOR IMMUNODIAGNOSTICS, BY TYPE, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 525
REST OF LATIN AMERICA: VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET FOR LATERAL FLOW ASSAYS, BY TYPE, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 526
REST OF LATIN AMERICA: VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET FOR MOLECULAR DIAGNOSTICS, BY TYPE, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 527
REST OF LATIN AMERICA: VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET, BY ANIMAL TYPE, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 528
REST OF LATIN AMERICA: VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET FOR COMPANION ANIMALS, BY TYPE, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 529
REST OF LATIN AMERICA: VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET FOR COMPANION ANIMALS, BY TECHNOLOGY, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 530
REST OF LATIN AMERICA: COMPANION ANIMALS MARKET FOR IMMUNODIAGNOSTICS, BY TYPE, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 531
REST OF LATIN AMERICA: COMPANION ANIMALS MARKET FOR MOLECULAR DIAGNOSTICS, BY TYPE, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 532
REST OF LATIN AMERICA: VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET FOR LIVESTOCK, BY TYPE, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 533
REST OF LATIN AMERICA: VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET FOR LIVESTOCK, BY TECHNOLOGY, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 534
REST OF LATIN AMERICA: LIVESTOCK MARKET FOR IMMUNODIAGNOSTICS, BY TYPE, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 535
REST OF LATIN AMERICA: LIVESTOCK MARKET FOR MOLECULAR DIAGNOSTICS, BY TYPE, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 536
REST OF LATIN AMERICA: VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET, BY END USER, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 537
MIDDLE EAST & AFRICA: VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET, BY REGION, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 538
MIDDLE EAST & AFRICA: VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET, BY PRODUCT, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 539
MIDDLE EAST & AFRICA: VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET, BY TECHNOLOGY, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 540
MIDDLE EAST & AFRICA: VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET FOR IMMUNODIAGNOSTICS, BY TYPE, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 541
MIDDLE EAST & AFRICA: VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET FOR LATERAL FLOW ASSAYS, BY TYPE, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 542
MIDDLE EAST & AFRICA: VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET FOR MOLECULAR DIAGNOSTICS, BY TYPE, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 543
MIDDLE EAST & AFRICA: VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET, BY ANIMAL TYPE, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 544
MIDDLE EAST & AFRICA: VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET FOR COMPANION ANIMALS, BY TYPE, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 545
MIDDLE EAST & AFRICA: VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET FOR COMPANION ANIMALS, BY TECHNOLOGY, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 546
MIDDLE EAST & AFRICA: COMPANION ANIMALS MARKET FOR IMMUNODIAGNOSTICS, BY TYPE, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 547
MIDDLE EAST & AFRICA: COMPANION ANIMALS MARKET FOR MOLECULAR DIAGNOSTICS, BY TYPE, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 548
MIDDLE EAST & AFRICA: VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET FOR LIVESTOCK, BY TYPE, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 549
MIDDLE EAST & AFRICA: VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET FOR LIVESTOCK, BY TECHNOLOGY, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 550
MIDDLE EAST & AFRICA: LIVESTOCK MARKET FOR IMMUNODIAGNOSTICS, B Y TYPE, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 551
MIDDLE EAST & AFRICA: LIVESTOCK MARKET FOR MOLECULAR DIAGNOSTICS, BY TYPE, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 552
MIDDLE EAST & AFRICA: VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET, BY END USER, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 553
GCC COUNTRIES: VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET, BY COUNTRY, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 554
GCC COUNTRIES: VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET, BY PRODUCT, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 555
GCC COUNTRIES: VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET, BY TECHNOLOGY, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 556
GCC COUNTRIES: VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET FOR IMMUNODIAGNOSTICS, BY TYPE, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 557
GCC COUNTRIES: VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET FOR LATERAL FLOW ASSAYS, BY TYPE, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 558
GCC COUNTRIES: VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET FOR MOLECULAR DIAGNOSTICS, BY TYPE, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 559
GCC COUNTRIES: VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET, BY ANIMAL TYPE, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 560
GCC COUNTRIES: VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET FOR COMPANION ANIMALS, BY TYPE, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 561
GCC COUNTRIES: VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET FOR COMPANION ANIMALS, BY TECHNOLOGY, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 562
GCC COUNTRIES: COMPANION ANIMALS MARKET FOR IMMUNODIAGNOSTICS, BY TYPE, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 563
GCC COUNTRIES: COMPANION ANIMALS MARKET FOR MOLECULAR DIAGNOSTICS, BY TYPE, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 564
GCC COUNTRIES: VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET FOR LIVESTOCK, BY TYPE, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 565
GCC COUNTRIES: VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET FOR LIVESTOCK, BY TECHNOLOGY, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 566
GCC COUNTRIES: LIVESTOCK MARKET FOR IMMUNODIAGNOSTICS, BY TYPE, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 567
GCC COUNTRIES: LIVESTOCK MARKET FOR MOLECULAR DIAGNOSTICS, BY TYPE, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 568
GCC COUNTRIES: VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET, BY END USER, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 569
KINGDOM OF SAUDI ARABIA: KEY MACROINDICATORS
 
 
 
 
TABLE 570
KINGDOM OF SAUDI ARABIA: VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET, BY PRODUCT, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 571
KINGDOM OF SAUDI ARABIA: VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET, BY TECHNOLOGY, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 572
KINGDOM OF SAUDI ARABIA: VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET FOR IMMUNODIAGNOSTICS, BY TYPE, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 573
KINGDOM OF SAUDI ARABIA: VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET FOR LATERAL FLOW ASSAYS, BY TYPE, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 574
KINGDOM OF SAUDI ARABIA: VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET FOR MOLECULAR DIAGNOSTICS, BY TYPE, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 575
KINGDOM OF SAUDI ARABIA: VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET, BY ANIMAL TYPE, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 576
KINGDOM OF SAUDI ARABIA: VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET FOR COMPANION ANIMALS, BY TYPE, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 577
KINGDOM OF SAUDI ARABIA: VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET FOR COMPANION ANIMALS, BY TECHNOLOGY, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 578
KINGDOM OF SAUDI ARABIA: COMPANION ANIMALS MARKET FOR IMMUNODIAGNOSTICS, BY TYPE, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 579
KINGDOM OF SAUDI ARABIA: COMPANION ANIMALS MARKET FOR MOLECULAR DIAGNOSTICS, BY TYPE, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 580
KINGDOM OF SAUDI ARABIA: VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET FOR LIVESTOCK, BY TYPE, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 581
KINGDOM OF SAUDI ARABIA: VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET FOR LIVESTOCK, BY TECHNOLOGY, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 582
KINGDOM OF SAUDI ARABIA: LIVESTOCK MARKET FOR IMMUNODIAGNOSTICS, BY TYPE, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 583
KINGDOM OF SAUDI ARABIA: LIVESTOCK MARKET FOR MOLECULAR DIAGNOSTICS, BY TYPE, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 584
KINGDOM OF SAUDI ARABIA: VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET, BY END USER, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 585
UNITED ARAB EMIRATES: KEY MACROINDICATORS
 
 
 
 
TABLE 586
UNITED ARAB EMIRATES: VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET, BY PRODUCT, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 587
UNITED ARAB EMIRATES : VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET, BY TECHNOLOGY, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 588
UNITED ARAB EMIRATES : VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET FOR IMMUNODIAGNOSTICS, BY TYPE, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 589
UNITED ARAB EMIRATES: VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET FOR LATERAL FLOW ASSAYS, BY TYPE, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 590
UNITED ARAB EMIRATES: VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET FOR MOLECULAR DIAGNOSTICS, BY TYPE, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 591
UNITED ARAB EMIRATES: VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET, BY ANIMAL TYPE, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 592
UNITED ARAB EMIRATES: VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET FOR COMPANION ANIMALS, BY TYPE, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 593
UNITED ARAB EMIRATES: VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET FOR COMPANION ANIMALS, BY TECHNOLOGY, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 594
UNITED ARAB EMIRATES: COMPANION ANIMALS MARKET FOR IMMUNODIAGNOSTICS, BY TYPE, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 595
UNITED ARAB EMIRATES: COMPANION ANIMALS MARKET FOR MOLECULAR DIAGNOSTICS, BY TYPE, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 596
UNITED ARAB EMIRATES: VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET FOR LIVESTOCK, BY TYPE, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 597
UNITED ARAB EMIRATES: VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET FOR LIVESTOCK, BY TECHNOLOGY, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 598
UNITED ARAB EMIRATES: LIVESTOCK MARKET FOR IMMUNODIAGNOSTICS, BY TYPE, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 599
UNITED ARAB EMIRATES: LIVESTOCK MARKET FOR MOLECULAR DIAGNOSTICS, BY TYPE, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 600
UNITED ARAB EMIRATES: VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET, BY END USER, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 601
REST OF GCC COUNTRIES: VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET, BY PRODUCT, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 602
REST OF GCC COUNTRIES : VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET, BY TECHNOLOGY, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 603
REST OF GCC COUNTRIES : VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET FOR IMMUNODIAGNOSTICS, BY TYPE, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 604
REST OF GCC COUNTRIES: VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET FOR LATERAL FLOW ASSAYS, BY TYPE, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 605
REST OF GCC COUNTRIES: VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET FOR MOLECULAR DIAGNOSTICS, BY TYPE, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 606
REST OF GCC COUNTRIES: VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET, BY ANIMAL TYPE, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 607
REST OF GCC COUNTRIES: VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET FOR COMPANION ANIMALS, BY TYPE, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 608
REST OF GCC COUNTRIES: VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET FOR COMPANION ANIMALS, BY TECHNOLOGY, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 609
REST OF GCC COUNTRIES: COMPANION ANIMALS MARKET FOR IMMUNODIAGNOSTICS, BY TYPE, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 610
REST OF GCC COUNTRIES: COMPANION ANIMALS MARKET FOR MOLECULAR DIAGNOSTICS, BY TYPE, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 611
REST OF GCC COUNTRIES: VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET FOR LIVESTOCK, BY TYPE, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 612
REST OF GCC COUNTRIES: VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET FOR LIVESTOCK, BY TECHNOLOGY, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 613
REST OF GCC COUNTRIES: LIVESTOCK MARKET FOR IMMUNODIAGNOSTICS, BY TYPE, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 614
REST OF GCC COUNTRIES: LIVESTOCK MARKET FOR MOLECULAR DIAGNOSTICS, BY TYPE, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 615
REST OF GCC COUNTRIES: VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET, BY END USER, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 616
REST OF MIDDLE EAST & AFRICA: VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET, BY PRODUCT, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 617
REST OF MIDDLE EAST & AFRICA : VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET, BY TECHNOLOGY, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 618
REST OF MIDDLE EAST & AFRICA : VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET FOR IMMUNODIAGNOSTICS, BY TYPE, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 619
REST OF MIDDLE EAST & AFRICA: VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET FOR LATERAL FLOW ASSAYS, BY TYPE, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 620
REST OF MIDDLE EAST & AFRICA: VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET FOR MOLECULAR DIAGNOSTICS, BY TYPE, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 621
REST OF MIDDLE EAST & AFRICA: VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET, BY ANIMAL TYPE, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 622
REST OF MIDDLE EAST & AFRICA: VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET FOR COMPANION ANIMALS, BY TYPE, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 623
REST OF MIDDLE EAST & AFRICA: VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET FOR COMPANION ANIMALS, BY TECHNOLOGY, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 624
REST OF MIDDLE EAST & AFRICA: COMPANION ANIMALS MARKET FOR IMMUNODIAGNOSTICS, BY TYPE, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 625
REST OF MIDDLE EAST & AFRICA: COMPANION ANIMALS MARKET FOR MOLECULAR DIAGNOSTICS, BY TYPE, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 626
REST OF MIDDLE EAST & AFRICA: VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET FOR LIVESTOCK, BY TYPE, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 627
REST OF MIDDLE EAST & AFRICA: VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET FOR LIVESTOCK, BY TECHNOLOGY, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 628
REST OF MIDDLE EAST & AFRICA: LIVESTOCK MARKET FOR IMMUNODIAGNOSTICS, BY TYPE, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 629
REST OF MIDDLE EAST & AFRICA: LIVESTOCK MARKET FOR MOLECULAR DIAGNOSTICS, BY TYPE, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 630
REST OF MIDDLE EAST & AFRICA: VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET, BY END USER, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 631
OVERVIEW OF STRATEGIES ADOPTED BY KEY PLAYERS IN VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET
 
 
 
 
TABLE 632
VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET FOR COMPANION ANIMALS: DEGREE OF COMPETITION
 
 
 
 
TABLE 633
VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET FOR LIVESTOCK: DEGREE OF COMPETITION
 
 
 
 
TABLE 634
VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET: REGION FOOTPRINT
 
 
 
 
TABLE 635
VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET: PRODUCT FOOTPRINT
 
 
 
 
TABLE 636
VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET: TECHNOLOGY FOOTPRINT
 
 
 
 
TABLE 637
VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET: ANIMAL TYPE FOOTPRINT
 
 
 
 
TABLE 638
VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET: DETAILED LIST OF KEY STARTUPS/SMES
 
 
 
 
TABLE 639
VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET: COMPETITIVE BENCHMARKING OF STARTUPS
 
 
 
 
TABLE 640
VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET: PRODUCT LAUNCHES & ENHANCEMENTS, JANUARY 2022–MAY 2025
 
 
 
 
TABLE 641
VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET: DEALS, JANUARY 2022–MAY 2025
 
 
 
 
TABLE 642
VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET: EXPANSIONS, JANUARY 2022–MAY 2025
 
 
 
 
TABLE 643
VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET: OTHER DEVELOPMENTS, JANUARY 2022–MARCH 2025
 
 
 
 
TABLE 644
IDEXX LABORATORIES, INC.: COMPANY OVERVIEW
 
 
 
 
TABLE 645
IDEXX LABORATORIES, INC.: PRODUCTS & SERVICES OFFERED
 
 
 
 
TABLE 646
IDEXX LABORATORIES, INC.: PRODUCT/SERVICE LAUNCHES & ENHANCEMENTS, JANUARY 2022–MAY 2025
 
 
 
 
TABLE 647
ZOETIS SERVICES LLC: COMPANY OVERVIEW
 
 
 
 
TABLE 648
ZOETIS SERVICES LLC: PRODUCTS & SERVICES OFFERED
 
 
 
 
TABLE 649
ZOETIS SERVICES LLC: PRODUCT ENHANCEMENTS, JANUARY 2022–MAY 2025
 
 
 
 
TABLE 650
ZOETIS SERVICES LLC: DEALS, JANUARY 2022–APRIL 2025
 
 
 
 
TABLE 651
ZOETIS SERVICES LLC: EXPANSIONS, JANUARY 2022–MAY 2025
 
 
 
 
TABLE 652
THERMO FISHER SCIENTIFIC INC.: COMPANY OVERVIEW
 
 
 
 
TABLE 653
THERMO FISHER SCIENTIFIC INC.: PRODUCTS & SERVICES OFFERED
 
 
 
 
TABLE 654
VIRBAC: COMPANY OVERVIEW
 
 
 
 
TABLE 655
VIRBAC: PRODUCTS & SERVICES OFFERED
 
 
 
 
TABLE 656
VIRBAC: DEALS, JANUARY 2022–MAY 2025
 
 
 
 
TABLE 657
VIRBAC: EXPANSIONS, JANUARY 2022–MAY 2025
 
 
 
 
TABLE 658
BIOMÉRIEUX: COMPANY OVERVIEW
 
 
 
 
TABLE 659
BIOMÉRIEUX: PRODUCTS & SERVICES OFFERED
 
 
 
 
TABLE 660
BIOMÉRIEUX: PRODUCT LAUNCHES & APPROVALS, JANUARY 2022–MAY 2025
 
 
 
 
TABLE 661
ANTECH DIAGNOSTICS, INC.: COMPANY OVERVIEW
 
 
 
 
TABLE 662
ANTECH DIAGNOSTICS, INC.: PRODUCTS & SERVICES OFFERED
 
 
 
 
TABLE 663
ANTECH DIAGNOSTICS, INC.: PRODUCT LAUNCHES, JANUARY 2022–MAY 2025
 
 
 
 
TABLE 664
ANTECH DIAGNOSTICS, INC.: EXPANSIONS, JANUARY 2022–MAY 2025
 
 
 
 
TABLE 665
INNOVATIVE DIAGNOSTICS: COMPANY OVERVIEW
 
 
 
 
TABLE 666
INNOVATIVE DIAGNOSTICS: PRODUCTS & SERVICES OFFERED
 
 
 
 
TABLE 667
NEOGEN CORPORATION: COMPANY OVERVIEW
 
 
 
 
TABLE 668
NEOGEN CORPORATION: PRODUCTS & SERVICES OFFERED
 
 
 
 
TABLE 669
NEOGEN CORPORATION: OTHER DEVELOPMENTS, JANUARY 2022–MAY 2025
 
 
 
 
TABLE 670
INDICAL BIOSCIENCE GMBH: COMPANY OVERVIEW
 
 
 
 
TABLE 671
INDICAL BIOSCIENCE GMBH: PRODUCTS & SERVICES OFFERED
 
 
 
 
TABLE 672
INDICAL BIOSCIENCE GMBH: PRODUCT ENHANCEMENTS, JANUARY 2022–MAY 2025
 
 
 
 
TABLE 673
AGROLABO S.P.A.: COMPANY OVERVIEW
 
 
 
 
TABLE 674
AGROLABO S.P.A.: PRODUCTS & SERVICES OFFERED
 
 
 
 
TABLE 675
BIONOTE: COMPANY OVERVIEW
 
 
 
 
TABLE 676
BIONOTE: PRODUCTS & SERVICES OFFERED
 
 
 
 
TABLE 677
BIONOTE: PRODUCT LAUNCHES, JANUARY 2022–MAY 2025
 
 
 
 
TABLE 678
BIONOTE: DEALS, JANUARY 2022–MAY 2025
 
 
 
 
TABLE 679
BIOGAL: COMPANY OVERVIEW
 
 
 
 
TABLE 680
BIOGAL: PRODUCTS & SERVICES OFFERED
 
 
 
 
TABLE 681
BIOCHEK: COMPANY OVERVIEW
 
 
 
 
TABLE 682
BIOCHEK: PRODUCTS & SERVICES OFFERED
 
 
 
 
TABLE 683
BIOCHEK: PRODUCT LAUNCHES, JANUARY 2022–MAY 2025
 
 
 
 
TABLE 684
BIOCHEK: DEALS, JANUARY 2022–MAY 2025
 
 
 
 
TABLE 685
MEGACOR DIAGNOSTIK GMBH: COMPANY OVERVIEW
 
 
 
 
TABLE 686
MEGACOR DIAGNOSTIK GMBH: PRODUCTS & SERVICES OFFERED
 
 
 
 
TABLE 687
MEGACOR DIAGNOSTIK GMBH: PRODUCT LAUNCHES & ENHANCEMENTS, JANUARY 2022–MAY 2025
 
 
 
 
TABLE 688
BIO-RAD LABORATORIES, INC.: COMPANY OVERVIEW
 
 
 
 
TABLE 689
BIO-RAD LABORATORIES, INC.: PRODUCTS & SERVICES OFFERED
 
 
 
 
TABLE 690
FASSISI, GMBH: COMPANY OVERVIEW
 
 
 
 
TABLE 691
BIOTANGENTS LIMITED: COMPANY OVERVIEW
 
 
 
 
TABLE 692
SKYER, INC.: COMPANY OVERVIEW
 
 
 
 
TABLE 693
BIOPANDA REAGENTS LTD.: COMPANY OVERVIEW
 
 
 
 
TABLE 694
SHENZHEN BIOEASY BIOTECHNOLOGY, INC.: COMPANY OVERVIEW
 
 
 
 
TABLE 695
GOLD STANDARD DIAGNOSTICS: COMPANY OVERVIEW
 
 
 
 
TABLE 696
BIO-X DIAGNOSTICS S.A.: COMPANY OVERVIEW
 
 
 
 
TABLE 697
DEMEDITEC DIAGNOSTICS GMBH: COMPANY OVERVIEW
 
 
 
 
TABLE 698
EUROIMMUN MEDIZINISCHE LABORDIAGNOSTIKA AG: COMPANY OVERVIEW
 
 
 
 
TABLE 699
BIOSTONE ANIMAL HEALTH: COMPANY OVERVIEW
 
 
 
 
LIST OF FIGURES
 
 
 
 
 
FIGURE 1
VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET SEGMENTATION & REGIONAL SCOPE
 
 
 
 
FIGURE 2
VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET: RESEARCH DESIGN
 
 
 
 
FIGURE 3
PRIMARY SOURCES
 
 
 
 
FIGURE 4
BREAKDOWN OF PRIMARY INTERVIEWS: BY COMPANY TYPE, DESIGNATION, AND REGION (SUPPLY SIDE)
 
 
 
 
FIGURE 5
BREAKDOWN OF PRIMARY INTERVIEWS: BY END USER, DESIGNATION, AND REGION (DEMAND SIDE)
 
 
 
 
FIGURE 6
BREAKDOWN OF PRIMARY INTERVIEWS: SUPPLY-SIDE AND DEMAND-SIDE PARTICIPANTS
 
 
 
 
FIGURE 7
SUPPLY-SIDE MARKET SIZE ESTIMATION: REVENUE SHARE ANALYSIS
 
 
 
 
FIGURE 8
REVENUE SHARE ANALYSIS ILLUSTRATION: IDEXX LABORATORIES, INC.
 
 
 
 
FIGURE 9
REVENUE ANALYSIS OF TOP FIVE COMPANIES: VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET (2024)
 
 
 
 
FIGURE 10
VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET: DEMAND-SIDE ANALYSIS
 
 
 
 
FIGURE 11
CAGR PROJECTIONS FROM ANALYSIS OF DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGES OF VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET (2025–2030)
 
 
 
 
FIGURE 12
CAGR PROJECTIONS: SUPPLY-SIDE ANALYSIS
 
 
 
 
FIGURE 13
TOP-DOWN APPROACH
 
 
 
 
FIGURE 14
BOTTOM-UP APPROACH
 
 
 
 
FIGURE 15
MARKET DATA TRIANGULATION METHODOLOGY
 
 
 
 
FIGURE 16
VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET, BY PRODUCT, 2025 VS. 2030 (USD MILLION)
 
 
 
 
FIGURE 17
VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET, BY TECHNOLOGY, 2025 VS. 2030 (USD MILLION)
 
 
 
 
FIGURE 18
VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET, BY ANIMAL TYPE, 2025 VS. 2030 (USD MILLION)
 
 
 
 
FIGURE 19
VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET FOR COMPANION ANIMALS, BY TYPE, 2025 VS. 2030 (USD MILLION)
 
 
 
 
FIGURE 20
VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET FOR COMPANION ANIMALS, BY TECHNOLOGY, 2025 VS. 2030 (USD MILLION)
 
 
 
 
FIGURE 21
VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET FOR LIVESTOCK, BY TYPE, 2025 VS. 2030 (USD MILLION)
 
 
 
 
FIGURE 22
VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET FOR LIVESTOCK, BY TECHNOLOGY, 2025 VS. 2030 (USD MILLION)
 
 
 
 
FIGURE 23
VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET, BY END USER, 2025 VS. 2030 (USD MILLION)
 
 
 
 
FIGURE 24
GEOGRAPHIC SNAPSHOT OF VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET
 
 
 
 
FIGURE 25
INCREASING INCIDENCE OF INFECTIOUS DISEASES TO FUEL MARKET GROWTH
 
 
 
 
FIGURE 26
CONSUMABLES SEGMENT AND CHINA ACCOUNTED FOR LARGEST MARKET SHARES IN 2024
 
 
 
 
FIGURE 27
ASIA PACIFIC REGION TO GROW AT HIGHEST CAGR DURING FORECAST PERIOD
 
 
 
 
FIGURE 28
CHINA TO REGISTER HIGHEST GROWTH RATE DURING FORECAST PERIOD
 
 
 
 
FIGURE 29
EMERGING ECONOMIES TO REGISTER HIGHER GROWTH RATES DURING FORECAST PERIOD
 
 
 
 
FIGURE 30
VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET: DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGES
 
 
 
 
FIGURE 31
EUROPE: PET POPULATION, 2021–2023
 
 
 
 
FIGURE 32
US: PET EXPENDITURE, DOGS VS. CATS, 2024 (USD)
 
 
 
 
FIGURE 33
VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET: PORTER’S FIVE FORCES ANALYSIS
 
 
 
 
FIGURE 34
VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET: NUMBER OF GRANTED PATENT APPLICATIONS (JANUARY 2014–MAY 2025)
 
 
 
 
FIGURE 35
TOP APPLICANT COUNTRIES/REGIONS FOR VETERINARY INFECTIOUS DISEASE DIAGNOSTICS PATENTS (JANUARY 2014–MAY 2025)
 
 
 
 
FIGURE 36
AVERAGE SELLING PRICE TREND FOR ELISA TEST KITS AND PCR TEST KITS, BY KEY PLAYER, 2024
 
 
 
 
FIGURE 37
AVERAGE SELLING PRICE OF ELISA AND PCR TEST KITS, BY REGION, 2024
 
 
 
 
FIGURE 38
INFLUENCE OF STAKEHOLDERS ON BUYING PROCESS FOR VETERINARY INFECTIOUS DISEASE DIAGNOSTIC PRODUCTS
 
 
 
 
FIGURE 39
KEY BUYING CRITERIA FOR TOP THREE END USERS
 
 
 
 
FIGURE 40
AI USE CASES
 
 
 
 
FIGURE 41
VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET: ECOSYSTEM MARKET MAP
 
 
 
 
FIGURE 42
VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET: VALUE CHAIN ANALYSIS
 
 
 
 
FIGURE 43
VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET: SUPPLY CHAIN ANALYSIS
 
 
 
 
FIGURE 44
VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET: ADJACENT MARKETS
 
 
 
 
FIGURE 45
INVESTMENT AND FUNDING SCENARIO FOR VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET PLAYERS, 2020–2024
 
 
 
 
FIGURE 46
VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET: GEOGRAPHIC SNAPSHOT
 
 
 
 
FIGURE 47
EXPECTED GROWTH IN NUMBER OF VETERINARIANS IN NORTH AMERICA, 2012–2030
 
 
 
 
FIGURE 48
NORTH AMERICA: VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET SNAPSHOT
 
 
 
 
FIGURE 49
ASIA PACIFIC: DOG POPULATION GROWTH, BY COUNTRY, 2024
 
 
 
 
FIGURE 50
ASIA PACIFIC: CAT POPULATION GROWTH, BY COUNTRY, 2024
 
 
 
 
FIGURE 51
ASIA PACIFIC: VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET SNAPSHOT
 
 
 
 
FIGURE 52
REVENUE ANALYSIS OF KEY PLAYERS IN VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET (2020–2024)
 
 
 
 
FIGURE 53
MARKET SHARE ANALYSIS OF KEY PLAYERS IN VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET FOR COMPANION ANIMALS (2024)
 
 
 
 
FIGURE 54
MARKET SHARE ANALYSIS OF KEY PLAYERS IN VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET FOR LIVESTOCK (2024)
 
 
 
 
FIGURE 55
RANKING OF KEY PLAYERS IN VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET, 2024
 
 
 
 
FIGURE 56
VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET: COMPANY EVALUATION MATRIX (KEY PLAYERS), 2024
 
 
 
 
FIGURE 57
VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET: COMPANY FOOTPRINT
 
 
 
 
FIGURE 58
VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET: COMPANY EVALUATION MATRIX (STARTUPS/SMES), 2024
 
 
 
 
FIGURE 59
VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET: BRAND/PRODUCT COMPARATIVE ANALYSIS
 
 
 
 
FIGURE 60
R&D EXPENDITURE OF KEY PLAYERS IN VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET, 2022–2024
 
 
 
 
FIGURE 61
EV/EBITDA OF KEY VENDORS
 
 
 
 
FIGURE 62
YEAR-TO-DATE (YTD) PRICE OF TOTAL RETURN AND 5-YEAR STOCK BETA OF KEY VENDORS
 
 
 
 
FIGURE 63
IDEXX LABORATORIES, INC.: COMPANY SNAPSHOT (2024)
 
 
 
 
FIGURE 64
ZOETIS SERVICES LLC: COMPANY SNAPSHOT (2024)
 
 
 
 
FIGURE 65
THERMO FISHER SCIENTIFIC INC.: COMPANY SNAPSHOT (2024)
 
 
 
 
FIGURE 66
VIRBAC: COMPANY SNAPSHOT (2024)
 
 
 
 
FIGURE 67
BIOMÉRIEUX: COMPANY SNAPSHOT (2024)
 
 
 
 
FIGURE 68
NEOGEN CORPORATION: COMPANY SNAPSHOT (2024)
 
 
 
 
FIGURE 69
BIO-RAD LABORATORIES, INC.: COMPANY SNAPSHOT (2024)
 
 
 
 

Methodology

This research study extensively utilized both primary and secondary sources. It involved analyzing various factors influencing the industry to identify segmentation types, industry trends, key players, the competitive landscape, key market dynamics, and strategies employed by key players.

Secondary Research

This research study utilized a variety of comprehensive secondary sources, including directories, databases such as Bloomberg Business, Factiva, and Dun & Bradstreet, white papers, annual reports, company house documents, investor presentations, and SEC filings from various companies. Secondary research was employed to gather information crucial for an in-depth, technical, market-oriented, and commercial analysis of the veterinary infectious disease diagnostics market. This approach also helped identify key players in the industry and allowed for classification and segmentation based on emerging trends at the most detailed level. Furthermore, significant developments pertaining to both market and technological perspectives were documented. A database of primary industry leaders was created as part of this secondary research.

Primary Research

In the primary research process, we interviewed a range of sources from both the supply and demand sides to gather qualitative and quantitative information for this report. On the supply side, we consulted individuals such as project, sales, marketing, and business development managers, as well as presidents, CEOs, vice presidents, chairpersons, chief operating officers, chief strategy officers, directors, and chief information officers, specifically related to the veterinary infectious disease diagnostics market. On the demand side, we spoke with veterinary healthcare professionals from veterinary reference laboratories, veterinary hospitals & clinics, and veterinary research institutes & universities.

A breakdown of the primary respondents is provided below:

Veterinary Infectious Disease Diagnostics Market

Note 1: C-level executives include CEOs, COOs, CTOs, and VPs.

Note 2: Other designations include sales, marketing, and product managers.

Note 3: Tiers are defined based on a company’s total revenue. As of 2024: Tier 1 = >USD 1 billion, Tier 2 = USD 500 million to USD 1 billion, and Tier 3 = < USD 500 million.

To know about the assumptions considered for the study, download the pdf brochure

Market Size Estimation

The total size of the veterinary infectious disease diagnostics market was determined after data triangulation from three approaches, as mentioned below. After each approach, the weighted average of the three approaches was taken based on the level of assumptions used in each approach.

Veterinary Infectious Disease Diagnostics Market

Data Triangulation

After arriving at the market size, the total market was divided into several segments and subsegments. Data triangulation and market breakdown procedures were employed wherever applicable to complete the overall market engineering process and arrive at the exact statistics for all segments and subsegments.

Market Definition

Veterinary infectious disease diagnostics encompasses various methods, including immunodiagnostics and molecular diagnostics, among others. These diagnostic tests utilize kits, reagents, consumables, and analyzers to identify the nature and cause of infectious diseases, as well as assess the health conditions of animals. They analyze samples such as plasma, serum, blood, urine, feces, and tissues to effectively diagnose animal diseases and disorders.

Stakeholders

  • Companion animal diagnostics manufacturers
  • Companion animal diagnostics distributors & suppliers
  • Companion animal R&D companies
  • Veterinary diagnostics and related instrument manufacturing companies
  • Veterinary reference laboratories
  • Veterinary hospitals and clinics
  • Veterinary research and consulting firms
  • Venture capitalists and investors
  • Government associations

Report Objectives

  • To define, describe, segment, and forecast the veterinary infectious disease diagnostics market by product, technology, animal type, end user, and region
  • To provide detailed information about the factors influencing market growth (such as drivers, restraints, opportunities, and challenges)
  • To analyze micromarkets with respect to individual growth trends, prospects, and contributions to the overall veterinary infectious disease diagnostics market
  • To analyze market opportunities for stakeholders and provide details of the competitive landscape for key players
  • To forecast the size of the veterinary infectious disease diagnostics market in five main regions (along with their respective key countries): North America, Europe, the Asia Pacific, Latin America, and the Middle East & Africa
  • To profile the key players in the veterinary infectious disease diagnostics market and comprehensively analyze their core competencies and market shares
  • To track and analyze competitive developments such as acquisitions, product launches, expansions, collaborations, agreements, and partnerships

Key Questions Addressed by the Report

Who are the leading industry players in the veterinary infectious disease diagnostics market?

The prominent players include IDEXX Laboratories, Inc. (US), Zoetis Services LLC (US), Thermo Fisher Scientific Inc. (US), Virbac (France), and bioMérieux (France).

Which geographic region is experiencing the highest growth rate in the veterinary infectious disease diagnostics market?

The Asia Pacific region is projected to grow at the highest CAGR during the forecast period.

Which technology segment is expected to dominate the market during the forecast period?

The immunodiagnostics segment is expected to dominate the market due to the increasing use of ELISA-linked tests and their ability to detect inactive or dormant viruses.

What factors are expected to challenge market growth?

Rising costs of veterinary diagnostic tests, lack of awareness about companion animal and livestock healthcare, and a shortage of veterinary professionals in emerging countries.

What is the expected CAGR for the market during the forecast period?

The veterinary diagnostics market is projected to grow at a CAGR of 8.0% during 2025−2030.

TABLE OF CONTENTS

METHODOLOGY

Adjacent Markets

Request Bundle Reports

Personalize This Research

  • Triangulate with your Own Data
  • Get Data as per your Format and Definition
  • Gain a Deeper Dive on a Specific Application, Geography, Customer or Competitor
  • Any level of Personalization
Request A Free Customisation

Let Us Help You

  • What are the Known and Unknown Adjacencies Impacting the Veterinary Infectious Disease Diagnostics Market
  • What will your New Revenue Sources be?
  • Who will be your Top Customer; what will make them switch?
  • Defend your Market Share or Win Competitors
  • Get a Scorecard for Target Partners
Customized Workshop Request
Forbes

Custom Market Research Services

We Will Customise The Research For You, In Case The Report Listed Above Does Not Meet With Your Requirements

Get 10% Free Customisation

Growth opportunities and latent adjacency in Veterinary Infectious Disease Diagnostics Market

Lauren

Mar, 2022

Which factors are fueling the growth of Asia Pacific region in the global Veterinary Infectious Disease Diagnostics Market?.

Christina

Mar, 2022

Under the technology segment, which sub-segment is expected to gain the largest share of the global Veterinary Infectious Disease Diagnostics Market?.

Megan

Mar, 2022

Can you please share some more light on the key players and different growth strategies adopted by them in the global Veterinary Infectious Disease Diagnostics Market?.

DMCA.com Protection Status